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Cells undergo morphological changes throughout the lifetime of organisms. The ability of 
cells to change shape is a necessity for key events such as cell division, attachment, and 
migration. As such, changes in cellular morphology are required during physiological 
processes such as immune responses, muscle contraction, neuritogenesis, wound healing, 
and angiogenesis. Similarly, pathological conditions, such as cancer, require changes in 
cellular morphology during disease progression. 
The cytoskeleton, a dynamic, structural framework within the cell, mediates changes 
in morphology and provides mechanical support. Three types of filaments form the 
cytoskeleton: actin filaments, microtubules, and intermediate filaments (Fig. 1). The filaments 
and their associating proteins are essential for morphological changes and also 
communicate with one another. Each filament consists of joined single subunits. The 
assembly of single subunits into filaments (polymerisation) or disassembly of filaments into 
single subunits (depolymerisation) underlies the dynamic nature of morphological changes. 





Figure 1. The cytoskeleton 
The three types of cytoskeletal filaments in a fibroblast as detected by fluorescence microscopy 
using specific probes. The intermediate filaments (using vimentin antibodies); microtubules 
(using tubulin antibodies); and the actin cytoskeleton (using fluorescent phalloidin) (adapted 
from (Herzog et al., 1994)). The schematic diagram and electron micrographs in the lower 
panels show how these filaments are built from subunits (adapted from Essential Cell Biology 
(Alberts et al., 2003)). 
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The actin cytoskeleton consists of networks and bundles that extend throughout the 
cell and underneath the plasma membrane. Dynamic regulation of the actin cytoskeleton is 
required for changes in cell shape, anchorage and motility. The Rho family of small 
GTPases have a central role in linking signalling pathways to remodelling of the actin 
cytoskeleton (Burridge and Wennerberg, 2004; Ridley, 2001a). Specifically, the turnover rate 
and localisation of actin (de)-polymerisation is controlled by a wide range of actin-associated 
proteins that are the (in)direct targets of Rho GTPase signaling pathways. For instance, the 
GTPase RhoA signals to the actin-binding and motor protein myosin to exert force on actin 
filaments leading to mechanical tension within a cell. In this way, activation of the RhoA 
pathway leading to actomyosin contractility enables cells to undergo morphological changes 
in response to stimuli. 
This thesis focuses on the function of p116Rip, an actin-binding protein with scaffold 





Rho GTPases regulate a wide spectrum of cellular processes (Etienne-Manneville and Hall, 
2002). Members of this family, including RhoA, Rac1 and Cdc42, were initially recognised as 
regulators of actin cytoskeleton and were subsequently shown to be involved in mechanical 
processes that require morphological changes such as cell polarity, division, adhesion, 
protrusion, and migration. However, subsequent research has demonstrated a role for Rho 
GTPases in a wide range of cellular activities besides actin remodelling including 
organisation of the microtubule cytoskeleton (Fukata et al., 2003; Wittmann and Waterman-
Storer, 2001), vesicular trafficking (Ridley, 2001b; Qualmann and Mellor, 2003), cell-cycle 
progression (Ridley, 2004), cytokinesis (Matsumura et al., 2001), apoptosis (Coleman and 
Olson, 2002), and gene transcription (Sahai and Marshall, 2002). In addition to their 
physiological role, Rho GTPases influence key processes in cancer, including cell 
transformation, survival, invasion, metastasis and angiogenesis (Ridley, 2004; Malliri and 
Collard, 2003; Sahai and Marshall, 2002). 
 
 
Figure 2. Rho GTPase activation 
Rho-family GTPases are activated 
by various upstream signals 
including receptor tyrosine kinases 
(RTK) such as PDGF or EGF, 
integrins (αβ) and G-protein-coupled 
receptors (GPCR) such as LPA 
(Moolenaar et al., 2004) or S1P. 
They alternate between a GDP-
bound (Rho-GDP) inactive state, 
and a GTP-bound (Rho-GTP) active 
state, which is regulated by GEFs, 
GAPs, and GDIs. S1P, sphingosine-
1-phosphate; LPA, lysophosphatidic 
acid; PDGF, platelet-derived growth 




Rho proteins were first identified by their homology to Ras hence the name Rho 
(Ras-homologous) (Madaule and Axel, 1985). Unlike Ras, Rho proteins themselves are not 
commonly mutated in tumours, instead their expression is often elevated in cancerous cells 
or mutations are found in proteins that regulate Rho protein activity. Constitutively active 
forms of RhoA and Rac1 induce an oncogenic phenotype in fibroblasts but to a much lesser 
degree than Ras. Moreover, the oncogenic properties of Ras have been shown to be 
critically dependent on RhoA, Rac1, and Cdc42 (Malliri and Collard, 2003; Ridley, 2004). 
Similar to other members of the Ras superfamily, Rho proteins regulate signal 
transduction by acting as molecular switches that cycle between GDP and GTP-bound 
states (Fig. 2). Activation of Rho GTPases (exchange of GDP by GTP) is stimulated by 
guanine-nucleotide exchange factors (GEFs) and is often associated with translocation of 
Rho proteins to the cell membrane (Rossman et al., 2005). Most Rho GTPases have an 
intrinsic ability to hydrolyse GTP to GDP, which can be promoted by GTPase-activating 
proteins (GAPs) (Moon and Zheng, 2003; Peck et al., 2002). Rho proteins can also be 
sequestered in the cytoplasm in their GDP-bound form by guanine-nucleotide dissociation 
inhibitors (GDIs) (Olofsson, 1999). Cell-surface receptors, including integrins, growth factor 
receptors and G-protein-coupled receptors, act upon GEFs and GAPs to modulate Rho 
GTPase activity. In the GTP-bound, activated state, Rho proteins specifically bind to effector 
molecules that facilitate downstream signalling (Bishop and Hall, 2000; Aspenstrom, 1999). 
The effects of Rho proteins on actin remodelling are well established. Cdc42 induces cell 
polarisation and arranges actin polymerisation to form finger-like filopodial protrusions. Rac1 
promotes the extension of lamellipodia at the leading edge of the cell and the formation of 
new focal contacts. RhoA promotes myosin-dependent contractility of actin filaments leading 
to the formation of actin stress fibres and focal adhesions. Additionally, Rho and Rac are 
mutually antagonistic since they suppress each other's activity, for example during cell 




The mammalian Rho family of GTPases, consisting of over 20 family members, can be 
divided into 5 subfamilies (Burridge and Wennerberg, 2004; Wherlock and Mellor, 2002; 
Wennerberg and Der, 2004). Initially, it was assumed that other members of the Rho 
GTPase family were functional equivalents of their more-studied counterparts Rac1, Cdc42 
and RhoA. In fact, they appear to have distinct effects on cell behaviour. For instance, 
RhoE/Rnd3, a member of the GTPase-deficient Rnd subfamily, inhibits Rho signalling. This 
occurs at two levels; by activating p190RhoGAP (Wennerberg et al., 2003) and inactivating 
the RhoA effector Rho kinase 1 (ROCK1) (Riento et al., 2003). Moreover, within the Rho-
related subfamily, comprised of RhoA, RhoB, and RhoC, members are not functionally 
redundant. The clearest difference in functions between the Rho members becomes 
apparent in cancer (as reviewed in (Wheeler and Ridley, 2004)). However, the Rho-related 
members do not appear to differ in their ability to interact with upstream GEFs or 
downstream effectors. The differences in function are most likely caused by differential 
transcriptional regulation and subcellular localisation (Wennerberg and Der, 2004; Wheeler 
and Ridley, 2004). RhoA is the best-characterised member of the Rho-related protein family. 




RhoA signalling: ROCK and mDia 
The RhoA pathway is required for the generation of tension in non-muscle cells that 
eventually leads to cell rounding, retraction, or contraction. The underlying force of 
contractility is mediated through phosphorylation of the motor protein myosin II. 
Phosphorylation of the regulatory myosin light chain (MLC) of myosin II enhances the actin-
binding and actin-induced ATPase activity of myosin. Together with changes in actin 
polymerisation and stabilisation, MLC phosphorylation triggers contractility (Amano et al., 
1998). RhoA induces myosin-dependent contractile force on actin filaments through the 
recruitment and activation of two of its effectors, the mammalian ortholog of Drosophila 
melanogaster diaphanous (mDia) and Rho-kinase (ROCK) (Fig. 3). 
 
 
Figure 3. RhoA signalling 
(a) Rho is a crucial modulator of remodelling of both the actin and microtubule cytoskeleton and 
cell motility, through the activation of its effector proteins ROCK and mDia. Activation of these 
effectors leads to the stabilisation of actin filaments, actin polymerisation, and increased 
actomyosin contractility, thereby promoting the formation of stress fibres, focal adhesion 
assembly and subsequent cell adhesion. See text for further details. ROCK, Rho-kinase; LIMK, 
LIM-kinase; MLC, myosin light chain; MLCP, MLC phosphatase; MLCK, MLC-kinase; SSH, 
slingshot; CIN, chronophin. (b) Actomyosin contractility induced by RhoA. The formation of actin 
stress fibres by transient expression of dominant active RhoV14 in a NIH3T3 fibroblast as 
visualised by phalloidin staining. 
 
ba 
ROCK activation positively contributes to actin-myosin dependent force generation 
through the phosphorylation of a number of downstream target proteins (Riento and Ridley, 
2003). ROCK induces an increase in MLC phosphorylation primarily by phosphorylation of 
the myosin-binding subunit (MBS) of myosin light chain phosphatase (MLCP), which leads to 
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inhibition of MLCP (Kimura et al., 1996; Kawano et al., 1999). Like MLC kinase (MLCK), 
ROCK can also phosphorylate MLC directly on residue Ser19 (Totsukawa et al., 2000; 
Amano et al., 1996). The antagonist of the Rho/ROCK pathway, MLCP, is a heterotrimer 
consisting of a catalytic subunit (PP1c), a 20-kDa protein of unknown function (M20), and 
MBS, which targets MLCP to its substrates including MLC (Ito et al., 2004). Drosophila 
melanogaster MBS mutants fail to complete dorsal closure, suggesting that this process 
requires spatially regulated myosin activation (Tan et al., 2003; Mizuno et al., 2002). 
Likewise, Caenorhabditis elegans mel-11, which encodes MBS, and let-502, which encodes 
ROCK, have opposite functions in embryonic elongation (Wissmann et al., 1999). Besides 
regulation of myosin phosphorylation, ROCK controls the stabilisation of F-actin by activating 
LIM kinases. LIM kinases phosphorylate and thereby inactivate the actin-severing protein 
cofilin (Maekawa et al., 1999), leading to stabilisation of actin filaments (Riento and Ridley, 
2003). A specific phosphatase called slingshot activates ADF/cofilin by removing the 
inhibitory phosphate (Niwa et al., 2002), for example during axon growth (Ng and Luo, 
2004). Another, unrelated cofilin phosphatase, chronophin, was identified recently (Gohla et 
al., 2005). Phosphorylation of other ROCK targets is also likely to play a role in actomyosin 
dependent contractility (Riento and Ridley, 2003). The Rho-ROCK pathway is essential for 
myosin contractility as shown by expression of dominant-negative forms of ROCK or by 
pharmacological inhibition of ROCK activity (Hirose et al., 1998; Ishizaki et al., 1997). 
ROCK acts in concert with the other downstream target of RhoA, mDia, to induce the 
formation of stress fibers (Watanabe et al., 1999; Nakano et al., 1999). mDia belongs to the 
family of formin-homology containing family of proteins, which have been implicated in actin 
assembly. The binding of RhoA to mDia leads to the unfolding and subsequent activation of 
this scaffold protein. mDia facilitates actin nucleation and actin polymerisation by the actin-
binding protein profilin (Li and Higgs, 2003). mDia also regulates the orientation and 
stabilisation of microtubules downstream of RhoA (Palazzo et al., 2001; Ishizaki et al., 2001), 
for example during cell migration (Watanabe et al., 2005). The mDia and ROCK pathways 
described here are involved in cell migration and neuritogenesis but also in RhoA-dependent 
signalling to the nucleus. 
 
RhoA signalling to the nucleus 
In addition to their effects on the actin cytoskeleton, Rho GTPases induce the expression of 
genes associated with cell proliferation and cell-cycle progression (Coleman et al., 2004). 
RhoA contributes to cell-cycle progression by increasing the levels of cyclin D1 through 
promoting sustained activation of ERK (Welsh et al., 2001) and repression of the CDK 
inhibitors p27Kip1 and p21Cip1 (Olson et al., 1998). Moreover, RhoA stimulates the 
expression of the c-fos and c-jun proto-oncogenes, which are members of the AP1 family of 
transcription factors that play a key role in normal and aberrant cell growth (Treisman et al., 
1998). RhoA stimulates c-jun expression through ROCK-dependent JNK activation, that 
occurs independently from the ability of ROCK to promote actin polymerisation (Marinissen 
et al., 2004). In contrast, expression from the c-fos serum response element (SRE) can be 
regulated by either MAPK signalling pathways or RhoA-dependent changes in actin 
dynamics. Ultimately, the pathways leading to c-jun and c-fos expression converge in the 
nucleus to regulate AP1 activity. 
Expression from the c-fos SRE regulatory element requires the binding of the serum 
response factor (SRF) and the association of SRF with different cofactors. The ternary 
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complex factor (TCF) family of Ets domain proteins are controlled through MAP kinase signal 
pathways (Treisman, 1996). In contrast, coactivators of the megakaryocytic acute leukemia 
(MAL) family are largely regulated through Rho GTPase signalling, as described in more 
detail below. Association of either TCF or MAL with the transcription factor SRF appears to 
be mutually exclusive (Miralles et al., 2003). 
 
Figure 4. Model for the role of 
MAL in Rho-mediated activation of 
SRF 
In serum-starved cells, MAL is 
predominantly cytoplasmic and 
confiscated by actin monomers. 
Upon serum stimulation, Rho is 
activated and causes an 
accumulation of F-actin and a 
corresponding decrease in the 
level of G-actin through the 
activation of the downstream 
effectors ROCK and mDia. As a 
consequence, MAL is no longer 
sequestered by G-actin and 
relocates to the nucleus where it 
associates with SRF as a dimer 
and activates SRE-mediated gene 
expression. SRF, serum response 
factor; SRE, serum response 
element; MAL, megakaryocytic 
acute leukaemia protein. 
 
 
Downstream of RhoA, SRF activity is regulated as a consequence of actin 
reorganisation. Activation of RhoA induces actin polymerisation and subsequent SRF 
activation through two effectors, ROCK and mDia, that together induce F-actin assembly and 
stabilisation (see Figure 3). The contribution of either the Rho-mDia-profilin or the Rho-
ROCK-LIMK-cofilin pathway to SRF activation appears to be cell type specific (Geneste et 
al., 2002). Recently, the SRF cofactor MAL, was shown to be a cellular sensor for the 
amount of unpolymerised, monomeric actin (G-actin) within cells (Miralles et al., 2003). Upon 
depletion of the G-actin pool, MAL redistributes to the nucleus where it mediates SRF 
activation (Fig. 4). MAL regulation thus provides a direct link between actin cytoskeletal 
dynamics in the cytoplasm and transcriptional activation in the nucleus. 
 
The RhoA pathway and neuritogenesis 
The organisation of the nervous system relies primarily on the morphological complexity of 
neurons. Neurons extend neurites, one of which differentiates into an axon, whereas the 
others become dendrites (Goldberg, 2003) (Fig. 5A). The growth cone, located at the tip of 
axons and dendrites, is a motile structure consisting of filopodia and lammellipodia that 
explores the environment (see Fig. 7B). The morphological changes that occur during the 
development of a neuron establish a high degree of polarity and depend on the regulation of 
the actin and microtubule cytoskeleton in response to extra-or intracellular cues (Luo, 2002; 
da Silva and Dotti, 2002). Accordingly, Rho GTPases are key regulators of neuronal polarity, 
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axon outgrowth and retraction, axon guidance, dendrite development, axon regeneration, 
and neuronal migration (Govek et al., 2005). 
 
 
Figure 5. Neuronal morphology 
(a) Schematic diagram of a typical vertebrate neuron. The arrows indicate the direction in which 
signals are transmitted. The axon conducts signals from the cell body, while the multiple 
dendrites receive signals from the axons of other neurons. The nerve terminals (growth cones) 
end on the dendrites or cell body of other neurons or on other cell types, such as muscle or gland 
cells. (b) LPA-induced neurite retraction of N1E-115 neuroblastoma cells. The LPA induced 
neurite retraction and cell rounding is dependent on the RhoA/ROCK pathway leading to 
actomyosin contractility. N1E-115 cells were serum starved for 4 hours and LPA (1 µM) was 
added, and subsequent changes in cell morphology were monitored by time-lapse microscopy 




Whilst Rac1 and Cdc42 are positive regulators of neurite outgrowth, RhoA inhibits 
neurite extension (Luo, 2000; Govek et al., 2005). As is the case with migration in other 
cells, the force that underlies directional movement of the neuronal axon and growth cone is 
generated by myosin (Brown and Bridgman, 2004). In neuroblastoma cells and in primary 
neurons, regulation of myosin II activity by the RhoA-ROCK pathway (Fig. 3, and Fig. 5B) 
has been shown to be crucial for neurite elongation, guidance, and branching (Luo, 2000). 
Overexpression of constitutively active RhoA induces neurite retraction and arrest growth in 
neuronal cell lines (Jalink et al., 1994; Kozma et al., 1997) and in primary neurons (Bito et 
al., 2000). Conversely, inactivation of RhoA by ADP-ribosylation using the C3-exoenzyme (a 
specific RhoA inhibitor) promotes neurite extension and growth cone motility and abolishes 
lysophosphatidic acid (LPA)-induced actomyosin contractility (Jalink et al., 1994). Likewise, 
inactivation of ROCK produces a similar effect in neuroblastoma cells and cerebellar granule 
cells (Hirose et al., 1998; Bito et al., 2000) and blocks LPA-induced neurite retraction and 
myosin II phosphorylation (Hirose et al., 1998). 
Antisense and knock-out strategies against the two different forms of the 
conventional myosin II present in neurons reveal that myosin IIA is required for neurite 
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retraction and myosin IIB induces growth cone motility and neurite outgrowth (Wylie and 
Chantler, 2003; Bridgman et al., 2001). Apart from myosin, neuronal development is 
regulated by signalling pathways that target other actin-binding proteins (Dent and Gertler, 
2003). For instance, in mammalian hippocampal neurons it was recently shown that the 
regulation of actin stability during neuritogenesis occurs via RhoA/ROCK-dependent 
modulation of the downstream effector and actin-binding protein profilin IIa (da Silva et al., 
2003). In addition, the actin depolymerisation factor cofilin, whose activity is regulated by the 
ROCK/LIMK pathway (Fig. 3), appears to be essential for axon growth in Drosophila 
melanogaster neurons (Ng and Luo, 2004). 
 
 




Treadmilling Filamentous (F)-actin is asymmetric and the two ends retain different kinetic 
characteristics. Actin monomers assemble much more rapidly at the 'barbed end' compared to the 
'pointed end' (these names correspond to the arrowhead appearance of myosin heads bound to 
actin filaments). Subunit treadmilling occurs at a steady state in which no net increase in 
polymerised actin is observed. The critical concentration (of actin monomers) of the pointed end is 
higher than that of the barbed end. At a monomer concentration situated between the values of 
critical concentrations of the barbed and pointed ends, there is a net dissociation of monomers 
(bound to ADP) from the pointed end, balanced by the addition of monomers (bound to ATP) to the 
barbed end. This leads to treadmilling; the relocation of the filament in the direction of the barbed 
end without affecting the length of the filament. ATP hydrolysis in the filament is essential to maintain 
treadmilling. See text for further details. 
 
 
Many actin-binding proteins (ABPs) bind 
to F- or G-actin and influence its 
dynamics or state. Among ABPs, some 
link actin filaments in a loose network 
(crosslinking proteins, e.g. filamin A), in 
tight bundles (bundling proteins, e.g. 
fascin and α-actinin) (see also Fig. 5), or 
anchor filaments to membranes (e.g. the 
members of the ERM 
(ezrin/radixin/moesin) family). Others bind 
to the barbed end of a filament and 
prevent further elongation (capping 
proteins, e.g. gelsolin), fragment filaments 
(severing proteins, e.g. ADF/cofilin), or 
might favour the depolymerisation of 
pointed ends (e.g. ADF/cofilin). ABPs 
also regulate the addition of monomers 
by sequestering them or favouring 
ADP/ATP exchange (e.g. profilin) 
(adapted from (Revenu et al., 2004)). 
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The actin cytoskeleton 
 
The above paragraphs underline the significance of dynamic actin regulation for cell 
morphology, migration, neuritogenesis, and modulation of gene transcription. The dynamic 
nature of the actin cytoskeleton is enabled by the ability of actin to rapidly switch between 
the filamentous polymeric form (F-actin) and a monomeric globular (G-actin) form. This 
allows a cell to modify the structure of the actin cytoskeleton quickly and adequately in 
response to extra- and intracellular signals. Actin filaments are polar structures, with a 
pointed (minus) and a barbed (plus) end. ATP-bound monomers bind preferentially to the 
barbed end of a pre-existing filament. ATP is rapidly hydrolysed following polymerisation, 
resulting in ADP-bound monomers at the barbed end of the filament. The subsequent loss of 
ADP-bound monomers at the pointed ends leads to growth of the filament in the direction of 
the barbed end, a process known as actin filament treadmilling (Box 1). 
The dynamics of the actin cytoskeleton are tightly regulated by a plethora of actin-
binding proteins (ABPs) and the hydrolysis of ATP by actin (Pollard and Borisy, 2003; 
Revenu et al., 2004; Rafelski and Theriot, 2004). ABPs initiate or terminate polymerisation, 
link actin filaments to each other or to the membrane, whilst others additionally act as 
scaffolding proteins (Box 1) (Winder and Ayscough, 2005). A higher order structure of actin 
filaments is accomplished by the joining of actin filaments by cross-linking and bundling 
ABPs (Fig. 6). Upstream signalling pathways regulate the activity of ABPs through changes 
in intracellular pH, protein phosphorylation, cytosolic Ca2+ concentrations, as well as 
phosphoinositide levels (Revenu et al., 2004; Janmey and Lindberg, 2004; Yin and Janmey, 
2003; Hilpela et al., 2004). 
 
Figure 6. Cross-linking of actin 
filaments by ABPs 
In vitro experiments using electron 
microscopy to visualise the structure 
of the actin filament network. In the 
presence of an actin cross-linking 
protein the actin network has a gel-
like organisation (above, adapted 
from (Niederman et al., 1983)). The 
presence of an actin-bundling 
protein leads to the formation of 
actin bundles (below) (Mulder et al., 
2003).  
 
The interplay of distinct ABP activities can lead to the formation of specific actin-
based structures. One example of this is the formation of filopodia and lamellipodia at the 
leading edge of cells during cell migration and in the neuronal growth cone (Fig. 7A, B). In 
lamellipodia, the actin filaments are short and highly branched with numerous barbed ends 
facing the leading edge. Branching occurs when the pointed end of one actin filament joins 
the side of another filament. This branching generally occurs at an angle of around 70° and 
is dependent on the action of distinct ABPs, the Arp2/3 (actin-related protein) complex. 
Capping proteins at the leading edge are responsible for the maintenance of short actin 
filaments in lamellipodia. Filopodia are thought to arise within the lamellipodial network when 
capping of actin filaments is prevented, resulting in the elongation and bundling of actin 
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filaments and subsequent protrusion of the cell membrane (Revenu et al., 2004; Pollard and 
Borisy, 2003) (Fig. 7C, D). 
 
 
Figure 7. Actin-based 
structures 
(a) Schematic diagram of 
the actin cytoskeleton in a 
migrating fibroblast. The 
different forms of actin 
filaments are illustrated. At 
the leading edge, branched 
actin filaments exist in 
lamellipodia and parallel F-
actin bundles in filopodia 
and microspikes (which are 
filopodia that not protrude 
beyond the membrane). The 
rear of the cell, the tail, 
contains contractile bundles; 
the actin stress fibres. 
Substrate adhesion sites are 
also indicated: focal 
complexes in lamellipodia 
and filopodia and focal 
adhesions at the termini of 
stress fibres. (b) Electron 
micrograph showing the 
cytoskeletal ultrastructure of 
a growth cone from an 
Aplysia bag cell neuron. 
Filopodia with F-actin 
bundles and lamellipodial 
actin networks are visible. 
Also indicated are the 
stabilised and dynamic 
microtubules (adapted from 











Representation of the mechanisms of 
lamellipodia and filopodia formation at the 
leading edge of cells. The branched 
dendritic structure of a keratocyte 
lamellipodium and the parallel actin 
bundles in the filopodium of a B16F mouse 
melanoma cell are shown (adapted from 
(Svitkina et al., 2003; Svitkina et al., 1997). 
(c) The schematic diagrams indicate how 
lamellipodia are formed when capping 
activity predominates. (d) Filopodia arise 
from the lamellar network when elongation 
of actin filaments predominates and/or 




Actin and actin-binding proteins in the nucleus 
Besides signalling to the nucleus through changes in actin dynamics in the cytoplasm as 
described above, recent evidence implicates a role for actin in several nuclear activities 
including transcription, chromatin remodelling and nucleocytoplasmic trafficking (Bettinger et 
al., 2004; Shumaker et al., 2003; Blessing et al., 2004; Olave et al., 2002). The nonmuscle 
isoform β-actin appears to be involved in transcription by all three classes of nuclear RNA 
polymerases. Firstly, actin appears to be essential for the initiation of transcription by RNA 
polymerase II (pol II) as the presence of β-actin in pre-initiation complexes was shown to be 
crucial for the formation of these complexes (Hofmann et al., 2004). Likewise, the 
association of β-actin with pol III is required for basal pol III transcription in a purified 
transcription system (Hu et al., 2004). Finally, β-actin associates with ribosomal RNA genes 
and is indispensable for transcription by pol I (Philimonenko et al., 2004). In the latter study it 
was also shown that the nuclear, actin-binding, and motor protein myosin I plays a positive 
role in pol I transcription. 
Additionally, nuclear actin is an integral component of chromatin remodeling 
complexes (for review, see Bettinger et al. 2004 and Olave et al. 2002). Actin stimulates the 
ATPase activity of the Brg1 subunit in the SWI/SNF-like BAF complex, and is required for 
association of the complex with the nuclear matrix (Zhao et al., 1998). Moreover, actin 
filament binding of the complex is regulated in a phosphatidylinositol 4,5-biphosphate (PIP2)-
dependent manner (Rando et al., 2002). Actin may fulfil a structural role by anchoring 
chromatin remodelling complexes to the nuclear matrix. Alternatively, the ATPase activity of 
actin may be used to regulate cycles of configuration and formation of the complex 
(Bettinger et al., 2004; Olave et al., 2002). 
Most of the nuclear actin is thought to be organised differently from its cytoplasmic 
filamentous form, as filamentous actin cannot be detected in the nucleus. Nuclear actin 
might exist in a monomeric form, as short filaments, or may adopt a novel oligomeric form 
(Bettinger et al., 2004). Therefore, it is tempting to assign a role for ABPs in nuclear actin 
regulation. Indeed, the list of ABPs that are localised in the nucleus is expanding (Rando et 
al., 2000; Bettinger et al., 2004). Nuclear localisation of ABPs is often specific and a target 
for regulation as illustrated for instance by the accumulation of the dephosphorylated, active 
form of the ABP cofilin in the nucleus (Olave et al., 2002). Furthermore, recent evidence 
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suggests that several members of the gelsolin family of ABPs have a role as transcriptional 
coactivators in the nucleus (Archer et al., 2005). Overall, the emerging evidence regarding 




Mouse p116Rip (predicted size 116kDa, Rho-interacting protein) was first identified as a 
putative binding partner of RhoA in a yeast two-hybrid screen using dominant active RhoV14 
as bait (Gebbink et al., 1997). The p116Rip sequence contains several protein interaction 
domains, including two pleckstrin homology domains (PH), two proline-rich stretches and a 
C-terminal coiled-coil domain, but lacks any known catalytic motif. 
 
Figure 8. Structural alignment of p116Rip
Schematic representation of the domain structure of p116Rip orthologues as defined by the 
SMART program. The degree of homology to murine p116Rip is indicated as the percentage of 
identity at amino acid level. The amino acid length of the p116Rip orthologues is indicated on the 
right and boxed. GenBankTM accession numbers: Mus musculus p116Rip, U73200; Rattus 
norvegicus p116Rip, AF311311; Homo sapiens M-RIP, AY296247; Xenopus laevis p116Rip, 
BC073109; Drosophila melanogaster outspread or CG3479-PA, NP_723879; Caenorhabditis 
elegans F10G8.8, NP_492655. See text for further details. 
The p116Rip protein is widely expressed in a variety of tissues as determined by Gebbink et 
al. and data present in several expression databases such as Gene Expression Atlas 
(http://symatlas.gnf.org/SymAtlas/). Initial results indicated that p116Rip expression in 
neuronal cells inhibited Rho- and LPA-induced contractility and promotes neurite outgrowth. 
 20
Chapter 1 
This thesis investigates p116Rip's cellular function with particular emphasis upon its interplay 
with RhoA, F-actin, and MBS. 
 
p116Rip orthologues 
The p116Rip protein is conserved throughout evolution. p116Rip orthologues are present in 
organisms ranging from Caenorhabditis elegans to Homo sapiens (Fig. 8). These 
orthologues all possess a similar domain organisation: two PH domains and a C-terminal 
coiled-coil structure. The PH domains, in particular, display a high degree of conservation. 
The N-terminal PH domains of the C.elegans (“F10G8.8”) and D.melanogaster (“outspread”) 
orthologues are 37% and 36% identical at amino acid (aa) level to that of mouse p116Rip, 
respectively. The second PH domains share 37% and 34% of identity with that of mouse 
p116Rip, respectively. Two proline-rich regions located in between the two PH domains are 
conserved only amongst the vertebrate homologues of p116Rip. Reduction of F10G8.8 
expression using RNA interference does not lead to any overt phenotype in C.elegans. 
However, mutations in the D.melanogaster orthologue have been identified that affect the 
wing function, hence the name “outspread”. Moreover, by yeast-two hybrid analysis, the 
F10G8.8 protein has been found to interact with several proteins whose function is unknown 
at present (for further information see www.flybase.org and www.wormbase.org). 
More recently the full-length rat and human orthologues of mouse p116Rip have been 
cloned (Lanson, Royals, and Claycomb, 2000, unpublished) (Koga and Ikebe, 2004; Surks 
et al., 2003). The mouse p116Rip gene is located on chromosome 11-B1.3, human p116Rip 
(M-RIP, myosin phosphatase-RhoA interacting protein) on chromosome 17-p11.2, and rat 
p116Rip on chromosome 10-q22. 
 
p116Rip isoforms and related proteins 
The p116Rip protein family includes p116Rip (splice variants isoform 1 and 2, see Fig. 9C), the 
splice variant KIAA0864 and a unique protein named Tara (Trio-associated repeat on actin) 
(Fig. 9A). 
The KIAA0864 gene has an insertion of an unusual large alternative exon between 
exon 15 and 16 of p116Rip. Consequently, KIAA0864 shares part of the C-terminal coiled-coil 
with p116Rip and contains other coiled-coil structures upstream that are encoded for by the 
alternative exon. As the full-length gene of KIAA0864 has not been cloned it is so far unclear 
whether the KIAA0864 gene includes also the downstream exons (1-13) of p116Rip that 
encode for the two PH domains. However, the splice variant KIAA0864 does exist at the 
transcriptional level as determined by rtPCR using primers specifically directed to the 
alternative exon (Fig. 9B). A recent study proposed a role for KIAA0864 in regulating neurite 
outgrowth since its expression is appears to be restricted to nervous tissue (Nakamura et al., 
2005). 
Additionally, two other splice variants of p116Rip are found in the NCBI database that 
are conserved at least in human and mice; a longer protein, isoform 1 (1037 aa residues) 
and a shorter protein, isoform 2 (1024 aa residues). The two isoforms differ due to an 
alternative use of exon 23. Isoform 2 includes exon 23 wherein a stop codon is found. 
However, isoform 1 skips exon 23 and uses exon 24 that also encodes a stop codon but 
results in a longer protein isoform (Fig. 9C). Recently, it was shown by rtPCR and microarray 
analysis that the expression of exon 23 in the p116Rip protein changes in a tissue specific 
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manner, indicating a tissue-specific expression of these two isoforms (Pan et al., 2004). This 






Figure 9. p116Rip isoforms and related proteins 
(a) The KIAA0864 protein is a splice variant of p116Rip containing an alternative exon between 
exon 15 and 16 of p116Rip. The Tara protein, a unique protein, is similar to the C-terminus of 
p116Rip including the second PH domain and the coiled-coil structure. The degree of homology 
to p116Rip is indicated as the percentage of identity at amino acid level. The amino acid length of 
the proteins is indicated on the right and boxed. Isoform 2 of p116Rip is depicted (see Fig. 9C). 
The domain structures of murine homologues are shown as defined by the SMART program. 
GenBankTM accession numbers: KIAA0864, BAC41453; Tara, NP_613045. See text for further 





NIH3T3 cells. The cDNAs of p116Rip and KIAA0864 (partial) (provided by Koga H., Kazusa DNA 
Research Institute, Japan, http://www.kazusa.or.jp/en/) were taken along as controls. KIAA0864 
expression is detected by two different primer sets that are directed to the alternative exon of 
KIAA0864. A primer set that is directed to an exon shared by p116Rip and KIAA0864, the 16th 
exon of p116Rip, was taken along as a control. (c) Murine p116Rip isoforms 1 and 2 (GenBankTM 
accession numbers NP_957697 and NP_036157) differ in the use of exon 23. While isoform 1 
skips exon 23 and uses exon 24 wherein the encoded sequence terminates (stop), isoform 2 
uses the sequence of exon 23 that also encodes for a stop codon. On the right the 
consequential difference in C-terminal amino acid sequence of the two isoforms is shown. 
 
Tara is a unique protein located on the mouse chromosome at 15-E1 and in human 
at 22-q13.1 and appears to be conserved only in vertebrates. The Tara protein is shorter 
than p116Rip, includes a PH domain and a C-terminal coiled-coil structure and shares a high 
degree of overall amino acid identity with the C-terminus of p116Rip. The PH domain of Tara, 
in particular, is highly similar to the second PH domain of p116Rip. Intriguingly, although the 
amino acid sequence and the domain organisation of p116Rip and Tara are very similar, the 
proteins appear to have contrasting effects upon actin organisation (Seipel et al., 2001). 
 
PH and coiled-coil domains of p116Rip
The most striking features of p116Rip are the two PH domains and the coiled-coil domain. 
The coiled-coil is one of the most abundant protein folding and assembly motifs consisting of 
α-helices wrapping around each other forming a supercoil. Although, coiled-coils have one 
of the simplest dimerisation interfaces they mediate highly selective protein associations. 
The coiled-coil domain of p116Rip is moderately similar to the coiled-coil domains of myosin 
family members, including myosin heavy chain and paramyosin. The coiled-coil of p116Rip 
was shown to mediate interactions with RhoA (in vitro), p116Rip itself, and MBS (Chapter 3 
and 4). 
PH domains are commonly found in a wide range of proteins involved in intracellular 
signalling or cytoskeletal organisation. The best-characterised function of PH domains is the 
binding to phosphoinositides, yet some mediate protein-protein interactions. Thus far, 
phosphoinositide binding has not been reported for the PH domains of p116Rip. Blast 
searches with the PH domains of p116Rip using the swissprot database reveal that the two 
PH domains are not significantly homologues to one another. However, both PH domains 
show moderate homology to known 3-phosphoinositide binding proteins (Gab27/p97, 
PtdIns(3,4,5)P3 (Maroun et al., 1999); PEPP1, PtdIns3P (Dowler et al., 2000); myosin X, 
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 (Axelrod, 1992)). The second PH domain in particular is 
similar to the PH domain of the PEPP1, 2, and 3 family members (33% identical, 46 % 
similar) the PH domain of AtPH (PtdIns3P (Dowler et al., 2000), 25% identical, 49% similar), 
the PH domain of DAPP1 (PtdIns(3,4,5)P3 and PtdIns(3,4)P2 (Dowler et al., 1999), 29% 
identical, 48% similar), and the PH domain of FAPP1 (PtdIns4P (Dowler et al., 2000), 27% 
identical, 45% similar). Both PH domains are also moderately similar to the PH domain of 
the tyrosine kinase Etk/BMX whose PH domain mediates the interaction with the FERM 
domain of focal adhesion kinase (Chen et al., 2001). The PH domain of another member of 
this family of tyrosine kinases, Btk, was shown to directly interact with F-actin (Yao et al., 
1999). The latter finding is of particular interest since the N-terminal PH domain of p116Rip is 





Figure 10. Conserved domains and putative interaction motifs of p116Rip
Alignment of mouse, human, and rat p116Rip using Vector NTI. Proline (P)-, serine (S)-, and 
arginine (R)-rich motifs, putative nuclear localisation sequence (NLS), and CaM binding site (IQ-
motif) are indicated. Residues conserved in two of the three orthologues are boxed in black, and 
absolutely conserved residues are indicated in grey. 
Putative motifs and interaction domains of p116Rip
Besides the PH-, and coiled-coil domains, p116Rip has several potential motifs that may 
mediate the interaction of p116Rip with other proteins, regulate p116Rip’s activity, or determine 
the localisation of p116Rip (Fig. 10). 
The two proline-rich regions (aa 164-172 and 285-296) match the consensus 
requirements for binding to SH3-domain (Cesareni et al., 2002) or WW-domain class IV 
containing proteins (Macias et al., 2002). Moreover, vertebrate p116Rip has two conserved 
arginine-rich regions (aa 528-537, and aa 581-591) and a less conserved serine-rich region 
(aa 179-190) of unknown function. The amino acid sequence of p116Rip contains one 
potential nuclear localisation signal that meets all the predicted requirements of an NLS (aa 
157-162, see http://cubic.bioc.columbia.edu/predictNLS). Accordingly, p116Rip displays 
partial nuclear localisation (Chapter 2). The coiled-coil domain of p116Rip contains a potential 
IQ motif (aa 695-714) that is conserved among the vertebrate orthologues. The IQ motif is a 
calmodulin (CaM)-binding sequence (using the calmodulin target database at 
http://calcium.uhnres.utoronto.ca/ctdb) and was first characterised in myosins. The IQ motif 
refers to a group of sequences that share the IQ motif found in a number of mostly Ca2+-
independent CaM binding proteins. Changes in intracellular Ca2+ levels regulate myosin 
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function through the CaM-associated IQ motifs. In addition, potential kinase phosphorylation 
sites are present in the p116Rip protein including sites for CaMKII, PKC, CKI, CKII, GSK3, 
p70S6K, PKG, and PKA. 
 
Potential role of p116Rip in disease 
There are some indications for a role of p116Rip in cancer. The human orthologue of p116Rip, 
M-RIP, is amplified in 4 of 22 patients with osteosarcoma, a bone forming cancer (Atiye et 
al., 2005). Furthermore, using an in vivo invasion assay combined with cDNA microarray 
analysis, the p116Rip gene was shown to be up-regulated by a ratio of 3.33 in invasive 
carcinoma cells of primary mammary tumours when compared to non-invasive cells derived 
from the same tumours (Wang et al., 2004). The genes that were identified in this study were 
generally involved in motility pathways and were co-ordinately up-regulated in invasive cells. 
This indicated that p116Rip, in concert with the other genes identified, may facilitate the 
enhanced migratory behaviour of these cells. The p116Rip gene is also up-regulated during 
the proliferation and self-renewal of pre-BI cells, indicating a role of p116Rip in the 
development of B cells (Hoffmann et al., 2002). As such, p116Rip expression might contribute 
to the specific homing, response of developing lymphocytes to a particular environment, 
proliferative expansion and the induction of V-DJ re-arrangements in early precursor B cells 
(Hoffmann and Melchers, 2003). There is also evidence of up-regulation of p116Rip gene 
transcription during renal failure in the chronic disease diabetes mellitus. Microanalysis and 
northern blotting showed a late-onset induction of the p116Rip gene in endothelin-induced 
mesangial cell hypertrophy, which is a model for diabetic renal failure (Goruppi et al., 2002). 
In diabetes, hypertrophy is associated with the progression to renal failure and is marked by 
an increase in overall protein synthesis, new gene transcription, and in some cases 
reorganisation of the actin cytoskeleton. Extraordinarily, p116Rip gene transcription was 
markedly down-regulated in the muscles of space-flown rats (Nikawa et al., 2004). Space 
travel affects physiological functions in many ways and causes muscle atrophy, the loss of 
muscle tissue, in particular. A model was proposed in which loss of gravity would decrease 
specifically the expression of cytoskeletal proteins, resulting in a disturbance of 
mitochondrial localisation in cells. The latter will most likely cause oxidative stress and a lack 
of energy leading to muscle atrophy. 
 
p116Rip protein complexes 
p116Rip and related proteins have been identified in several protein complexes. Using a 
proteomics based approach, KIAA0864 was shown to be selectively recruited to the EGF-
receptor complex upon receptor stimulation, suggesting a role for KIAA0864 in EGF 
signalling (Blagoev et al., 2003). p116Rip itself was found to be in a complex consisting of 
citron-N, a brain-specific Rho-binding protein, ROCK2, profilin IIa, and LIMK (Camera et al., 
2003). The protein complex was identified by passing mouse brain lysate through a citron-N 
C-terminal fragment affinity column and performing subsequent mass spectrometry on 
specific eluted proteins. Citron-N appeared to be enriched and associated with the Golgi 
apparatus of hippocampal neurons. Furthermore, citron-N was shown to be necessary for 
Golgi positioning and structural organisation. Therefore a model was proposed that involves 
a function of the protein complex in Golgi maintenance through local recruitment of Rho-




Outline of this thesis 
 
Activation of the RhoA pathway leads to reorganisation of the actin cytoskeleton. 
Furthermore, changes in actin dynamics induced by the Rho pathway causes activation of 
the transcription factor SRF and subsequent SRE gene transcription. This thesis assesses 
the function of p116Rip in the RhoA pathway leading to contractility of the actin cytoskeleton 
and subsequent activation of SRF. 
In Chapter 2 we identify p116Rip as an F-actin binding protein with the ability of 
bundling F-actin in vitro and report that expression of p116Rip leads to disruption of actin 
cytoskeletal structures. Chapter 3 describes the interaction of p116Rip with MBS and reveals 
an essential function of p116Rip in neurite outgrowth. Chapter 4 demonstrates that p116Rip 
inhibits RhoA-induced activation of the transcription factor SRF without affecting active RhoA 
levels. Additionally, we attest the ability of p116Rip to oligomerise and discuss the underlying 
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Chapter 2 




p116Rip is a ubiquitously expressed protein that was originally identified as a putative binding 
partner of RhoA in a yeast two-hybrid screen. Overexpression of p116Rip in neuroblastoma 
cells inhibits RhoA-mediated cell contraction induced by lysophosphatidic acid (LPA); so far, 
however, the function of p116Rip is unknown. Here we report that p116Rip localises to 
filamentous actin (F-actin)-rich structures, including stress fibres and cortical microfilaments, 
in both serum-deprived and LPA-stimulated cells, with the N terminus (residues 1–382) 
dictating cytoskeletal localisation. In addition, p116Rip is found in the nucleus. Direct 
interaction or colocalisation with RhoA was not detected. We find that p116Rip binds tightly to 
F-actin (Kd ~0.5 µm) via its N-terminal region, while immunoprecipitation assays show that 
p116Rip is complexed to both F-actin and myosin-II. Purified p116Rip and the F-actin-binding 
region can bundle F-actin in vitro, as shown by electron microscopy. When overexpressed in 
NIH3T3 cells, p116Rip disrupts stress fibres and promotes formation of dendrite-like 
extensions through its N-terminal actin-binding domain; furthermore, overexpressed p116Rip 
inhibits growth factor-induced lamellipodia formation. Our results indicate that p116Rip is an 
F-actin-binding protein with in vitro bundling activity and in vivo capability of disassembling 





Dynamic remodelling of the actin-based cytoskeleton drives cell shape changes, cell 
division, and motility. Cytoskeletal remodelling involves the assembly and disassembly of 
filamentous actin (F-actin) and is effectuated by cell-surface receptors that signal through 
small GTPases of the Rho family, notably RhoA, Rac and Cdc42 (Ridley, 2001; Etienne-
Manneville and Hall, 2002). Many different actin-associated proteins participate in regulating 
actin dynamics in concert with Rho GTPases (Ayscough, 1998; Ridley, 1999; Svitkina and 
Borisy, 1999; Borisy and Svitkina, 2000; Wear et al., 2000; Higgs and Pollard, 2001; 
Janmey, 2001). Some actin-binding proteins promote organisation of actin into higher-order 
structures, whereas others control actin remodelling in response to extracellular stimuli such 
as growth factors, hormones, or cell adhesion cues. Although only few proteins bind actin 
monomers, there are more than 100 that bind polymeric F-actin, and many of them induce 
cross-linking or bundling of F-actin (dos Remedios and Thomas, 2001). 
In our ongoing studies to delineate Rho signalling by the lipid growth factor 
lysophosphatidic acid (LPA) (Kranenburg et al., 1999; Moolenaar, 1999), we previously 
identified a ubiquitously expressed protein of 116 kDa, provisionally named p116Rip, which 
binds relatively weakly to activated RhoA in a yeast two-hybrid assay (Gebbink et al., 1997). 
The p116Rip sequence predicts several protein interaction domains, including at least one PH 
domain, two proline-rich stretches, and a C-terminal region predicted to form a coiled-coil 
domain. This suggests that p116Rip may have a scaffolding role recruiting different proteins 
into a RhoA-regulated macromolecular complex. When overexpressed in N1E-115 
neuroblastoma cells, p116Rip promotes cell flattening and process extension and inhibits 
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cytoskeletal contraction in response to LPA (Gebbink et al., 1997). The p116Rip phenotype 
was reminiscent of what is observed after RhoA inactivation (using dominant-negative RhoA 
or C3 toxin), which led to the suggestion that p116Rip may negatively regulate RhoA 
signalling (Gebbink et al., 1997). However, the function of p116Rip remains unknown; 
importantly, no evidence that p116Rip binds directly to RhoA in mammalian cells has been 
discovered (Gebbink et al., 2001). 
In the present study, we set out to characterise p116Rip in further detail. We find that 
p116Rip, rather than directly binding to RhoA, interacts with F-actin via its N-terminal region 
and colocalises with dynamic F-actin structures such as stress fibres, cortical microfilaments, 
filopodia, and lamellipodial ruffles. Furthermore, we show that p116Rip induces bundling of F-
actin in vitro, with the bundling activity residing in the N-terminal region. Yet overexpression 
of p116Rip or its N-terminal actin-binding domain disrupts the actin cytoskeleton and thereby 
interferes with growth factor-induced contractility and lamellipodia formation. Our studies 
specify p116Rip as a novel F-actin-binding protein and demonstrate that p116Rip can affect, 





We originally isolated p116Rip through its interaction with activated RhoA-V14 in yeast two-
hybrid assays in which the RhoA isoprenylation site was mutated to prevent membrane 
targeting (Gebbink et al., 1997); no interaction was found with other small GTPases, notably 
activated RhoB, RhoE, Rac1, Cdc42, and Ras. The interaction between p116Rip and RhoA-
V14 was relatively weak, however, and in subsequent studies, we have been unable to 
confirm that p116Rip interacts with RhoA in mammalian cells (Gebbink et al., 2001), 
supplementary data). Furthermore, overexpression of p116Rip in COS-7 cells did not 
significantly influence the activation state of endogenous RhoA (Chapter 4). We therefore 
conclude that p116Rip is unlikely to be a high-affinity binding partner and/or negative 
regulator of RhoA. 
 
p116Rip localises to dynamic actin-rich structures and the nucleus 
As a first step in elucidating the function of p116Rip, we examined its subcellular localisation 
in N1E-115 and NIH3T3 cells using a polyclonal anti-p116Rip antibody raised against the 
putative "RhoA-binding domain" (RBD; (Gebbink et al., 1997)). Cells were simultaneously 
double-stained with rhodamine-phalloidin to visualise F-actin. In serum-deprived N1E-115 
cells, endogenous p116Rip colocalises with F-actin structures, especially the actin-rich 
microspikes (Fig. 1, top). After stimulation with LPA, a potent activator of RhoA, N1E-115 
cells rapidly round up and neurites retract (Jalink et al., 1993; Jalink et al., 1994). In those 
contracted cells, p116Rip is found relocalised to the contractile actomyosin ring at the cell 
cortex (Fig. 1). In NIH3T3 cells, maintained either in serum-free medium or stimulated with 
LPA, p116Rip colocalises with F-actin-rich structures, particularly along stress fibres, at 
cortical microfilaments, and at the leading edge of lamellipodia (Fig. 1, bottom). Of note, 
p116Rip staining is also detected in the cytoplasm and the nucleus (Fig. 1, bottom). 
Specificity of the observed immunostaining was confirmed by using the GST-RBD 
polypeptide antigen (previously termed ∆2; (Gebbink et al., 1997)), which blocked the 
 36
Chapter 2 
p116Rip fluorescence signal. Furthermore, p116Rip transfected into COS-7 or N1E-115 cells 
showed the same subcellular distribution pattern as endogenous p116Rip: colocalisation with 
F-actin-rich structures as well as nuclear and cytoplasmic staining (Fig. 2B and results not 
shown). No colocalisation with endogenous RhoA was detected in either N1E-115 or 
NIH3T3 cells (results not shown). 
 
The NT region of p116Rip dictates subcellular localisation 
The subcellular localisation of p116Rip raises the possibility that p116Rip is an F-actin-binding 
protein. To test this notion, we examined the intracellular localisation of distinct domains of 
p116Rip and determined their detergent solubility. p116Rip contains several putative protein 
and phospholipid interaction motifs, including a central PH domain, an N-terminal PH domain 
(aa 43–152; not noted previously (Gebbink et al., 1997)); two proline-rich regions, and a C-
terminal coiled-coil region (Fig. 2A). The putative "RhoA-binding domain" (RBD) that was 
isolated in yeast two-hybrid screens (Gebbink et al., 1997) overlaps with the coiled-coil 
region, as indicated in Fig. 2A. 
We generated HA-tagged p116Rip and three truncated versions (HA-tagged) 
encoding the CT coiled-coil region, the RBD and the NT half (NT-p116Rip; Fig. 2A). The 
various cDNA constructs were transiently transfected into N1E-115 cells and the subcellular 
localisation and detergent solubility of the resulting proteins were analysed. Transfected HA-
p116Rip, like endogenous p116Rip, localises to cortical F-actin (and the nucleus; data not 
shown). In contrast, the p116Rip-CT and RBD polypeptides display nuclear and cytoplasmic 
localisation (Fig. 2B). In keeping with these results, the CT and RBD truncation mutants are 
largely Triton-soluble, whereas full-length p116Rip (transfected and endogenous) is about 
50% insoluble (Fig. 2C and results not shown), consistent with association with the 
cytoskeleton. 
Similar to full-length p116Rip, the N terminus of p116Rip (NT-p116Rip) colocalises with 
F-actin and is also detectable in the nucleus (Fig. 2D and results not shown). When the NT-
p116Rip-expressing cells were analysed at >48 h after transfection, however, the F-actin 
cytoskeleton was largely disrupted (see below). Collectively, these results indicate that the 
N-terminal part of p116Rip (aa 1–382) determines its subcellular localisation. 
 
Binding of p116Rip to F-actin 
F-actin associates with the motor protein myosin-II to generate contractile forces in non-
muscle cells. In metabolically labelled N1E-115 cells, we found that endogenous p116Rip as 
well as the purified polypeptide NT-p116Rip (fused to GST) coprecipitated with proteins of 43 
and 200 kDa (Fig. 3A, lanes 2 and 4, respectively). Immunoblot analysis confirmed that the 
43-kDa protein is actin (not shown), and revealed that the 200 kDa protein represents the 
heavy-chain of non-muscle myosin-II (Fig. 3B). Although the reciprocal precipitations yielded 
variable results, our data support the notion that p116Rip associates with actomyosin in vivo. 
We next investigated the actin-binding properties of NT-p116Rip. As shown in Fig. 4A, 
NT-p116Rip (fused to GST) cosediments with purified F-actin, as did α-actinin, whereas GST 
alone and BSA did not. Fusion proteins containing the C-terminal regions of p116Rip (CT and 
RBD) failed to cosediment with F-actin (results not shown). It thus seems that the N-terminal 
region of p116Rip contains an F-actin-binding domain. We next examined the binding affinity 
of full-length p116Rip for F-actin. Increasing concentrations of purified F-actin (0–3.5 µm) 
were mixed with a fixed amount of p116Rip (1 µm). After high-speed centrifugation, the 
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amount of p116Rip cosedimenting with F-actin was determined. From the resulting binding 
curve we estimate that p116Rip binds to F-actin with an apparent dissociation constant (Kd) of 
about 0.5 µm (Fig. 4B). 
 
Figure 1. Immunofluorescence analysis of p116Rip localisation 
Cells were grown on glass coverslips and treated as follows: N1E-115 or NIH3T3 cells were 
cultured in serum-free medium and were either left untreated or were stimulated with LPA (1 µM) 
for 10 min to induce RhoA-mediated cytoskeletal contraction and cell rounding (N1E-115 cells) or 
stress fibres (3T3 cells). NIH3T3 cells were used to visualise lamellipodia and membrane ruffles. 
Abundant filopodia (microspikes) are observed in serum-starved N1E-115 cells. The distribution 
of endogenous p116Rip was visualised by immunofluorescence using polyclonal anti-p116Rip 
antibody (raised against part of the coiled-coil region, aa 545–823 (Gebbink et al., 1997)), 
whereas F-actin was detected by rhodamine-conjugated phalloidin. Merges are shown in green 
(p116Rip) and red (F-actin). p116Rip is seen to colocalise with filopodia, cortical actin, membrane 
ruffles, and stress fibres. In addition, p116Rip is found in the nucleus (best visible in the two 
bottom rows) and the cytoplasm. Scale bars, 10 µm. 
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Figure 2. Association of p116Rip 
with the actin cytoskeleton 
(a) Expression constructs used 
for transfection in N1E-115 cells 
encode FLp116Rip and three 
deletion mutants encompassing 
the complete C terminus 
(construct CT; aa 545–1024) or 
part of the C terminus (construct 
RBD; aa 545–823) including the 
"RhoA-binding domain," as 
indicated, or the N-terminal PH 
domain of p116Rip (construct NT; 
aa 1–382.). P-rich, proline-rich 
regions. The N-terminal PH 
domain was not recognised 
earlier (Gebbink et al., 1997). (b) 
Confocal analysis of transfected 
N1E-115 cells using anti-p116Rip 
antibody and rhodamine 
conjugated to phalloidin (red 
staining only in left). Transfected 
full-length p116Rip colocalises 
with cortical actin, whereas 
truncation mutants CT and RBD 
are found in the cytoplasm and in 
the nucleus. (c) Solubility of 
transfected full-length or 
truncated p116Rip in a buffer 
containing 0.1% Triton-X-100, as 
examined by subcellular 
fractionation into a supernatant 
(s) and pellet (p) fraction. The 
p116Rip antibody was used for 
detection on Western blot. Full-
length p116Rip is partially 
insoluble while the truncation 
mutants CT and RBD are largely 
soluble. IB, immunoblot. (d) N1E-
115 cells were transfected with 
an HA-tagged construct encoding 
a truncated version of p116Rip encompassing the N-terminal PH domain (construct HA-NT; aa 1–382). 
Cells were fixed 24 h after start of transfection, and the localisation of the expressed NT construct was 
analysed by immunofluorescence using anti-HA antibody. F-actin was stained with rhodamine-
conjugated phalloidin (red staining). It is seen that the NT protein colocalises with F-actin. 
 
To define the N-terminal regions mediating F-actin binding in further detail, we made 
various deletion mutants and determined their F-actin cosedimentation properties, as 
illustrated in Fig. 4C. Whereas p116Rip has no obvious sequence homology to known actin-
binding proteins, potential actin-binding motifs include the N-terminal PH domain (Yao et al., 
1999) as well as a stretch of positively charged residues (KKKRK, aa 157–161) that could 
interact with the highly anionic actin filament (Tang and Janmey, 1996). We found that one 
deletion mutant (∆6; aa 1–212), comprising both the PH domain and the positive stretch, can 
bind F-actin, whereas the other mutants cannot (Fig. 4C). Thus, the extreme N terminus (aa 
1–43), the PH domain, and the adjacent cationic residues are all necessary to mediate F-
actin binding. Further definition of the critical actin-binding motif(s) within the N-terminal 
region must await future studies. 
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Figure 3. Association of p116Rip with actomyosin 
complexes in vivo 
(a) N1E-115 neuroblastoma cells were starved in 
methionine/cysteine-free medium for 30 min and then 
labeled for 4 h with [35S]methionine/cysteine. 
Endogenous p116Rip was immunoprecipitated (IP) using 
polyclonal anti-p116Rip antibodies (arrow). Normal rabbit 
serum (NRS) was used as a control for 
immunoprecipitation (left). GST pull-down assays were performed with either GST alone or the 
GST fusion protein containing the isolated actin-binding domain (GST-NT-p116 Rip; right lanes). 
Precipitates were subjected to SDS-PAGE and analysed by autoradiography. (b) Western blot 
analysis of precipitates and GST pull-down assays using polyclonal anti-p116Rip and anti-myosin-
II antibodies, endogenous p116Rip, and myosin-II were immunoprecipitated using polyclonal anti-
p116Rip antibodies and polyclonal anti-myosin-II antibodies, respectively (left lanes). Normal 
rabbit serum (NRS) was used as a control for immunoprecipitation. GST pull-down assays were 
performed with either GST alone or the GST fusion protein containing the isolated actin-binding 
domain (GST-NT-p116Rip; right lanes). Myosin coprecipitates in p116Rip immuno-complexes and 





Figure 4. (previous page) Direct binding of p116Rip to F-actin in vitro 
(a) Purified proteins GST-NT, GST alone, α-actinin, p116Rip-GST, p116Rip-Myc, or BSA were 
incubated with (+) or without (-) in vitro prepared actin filaments. F-actin was subsequently 
pelleted by ultracentrifugation. Co-sedimentation of the various proteins with F-actin was 
analysed by SDS-PAGE followed by Coomassie staining of the gel. GST-NT, p116Rip-GST, 
p116Rip-Myc, and α-actinin, but not GST or BSA, cosediment with F-actin (right). None of the 
proteins tested was pelleted if F-actin was omitted form the reaction mixture (left; not shown for 
BSA and α-actinin). S, supernatant fraction; P, pellet fraction. (b) Direct plot of binding of p116Rip-
GST to F-actin. A fixed amount of p116Rip-GST (1 µM) was mixed with various amounts of F-
actin (0–3.5 µM), followed by ultracentrifugation. Amounts of the free and bound p116Rip were 
quantified as described. The percentage of bound p116Rip-GST was plotted against the 
concentration of F-actin. The curve was obtained by nonlinear fitting to a rectangular hyperbola. 
The apparent Kd was estimated to be 0.5 µM. (c) Diagram of purified recombinant p116Rip 
proteins that have deletions in the actin-binding domain (NT) (∆5, aa 1–152; ∆6; aa 1–212; ∆7, 
aa 43–152; ∆8, aa 43–212; ∆9, aa 212–390) and that are fused to GST (right). Cosedimentation 
of the deletion mutants with F-actin was determined by Western blot analysis using a GST 
antibody. ++, stretch of positive residues, KKKRK, at position 157–161. 
 
 
p116Rip induces bundling of F-actin in vitro via its N-terminal region 
We next examined the ability of p116Rip and NT-p116Rip to induce actin cross-linking in vitro, 
using α-actinin as a positive control. Myc-p116Rip and GST-p116Rip were isolated from 
transfected COS-7 cells using affinity chromatography, and protein purity was determined by 
Coomassie Blue staining. Myc-p116Rip, like GST-p116Rip, binds F-actin, as shown by 
cosedimentation assays using lysates from transfected COS-7 cells (see Fig. 6A, left). 
Because the dimeric nature of GST could mediate artifactual actin cross-linking by GST-
p116Rip, we also used Myc-p116Rip. Purified GST-p116Rip, Myc-p116Rip, α-actinin, or GST 
alone were incubated with F-actin, and the samples were subsequently analysed by electron 
microscopy. In the absence of p116Rip or in the presence of GST alone, long actin filaments 
were randomly distributed all over the grid and no organised actin bundles were observed 
(Fig. 5A). In the presence of either GST-p116Rip or Myc-p116Rip, however, F-actin became 
organised into thick bundles similar to those formed by the actin-bundling protein α-actinin 
(Fig. 5, B, C, and D). The bundles consisted of many actin filaments closely aligned in 
juxtaposition, with no branching of filaments observed.  
We also tested the isolated N-terminal actin-binding domain (NT-p116Rip; aa 1–382) 
and the C-terminal coiled-coil region (CT-p116Rip; aa 545–1024) for bundling activity. In 
these experiments, GST-fusion proteins were produced in bacteria followed by GST 
cleavage. As expected, the NT-p116Rip protein induced actin bundling similar to full-length 
p116Rip, whereas no actin bundles were observed after incubation of F-actin with the CT 
polypeptide (Fig. 5, E and F). Thus, p116Rip induces bundling of F-actin in vitro through its N-
terminal actin-binding domain. 
 
Expression of p116Rip or the N-terminal actin-binding domain promotes stress fiber 
disassembly and process outgrowth 
We investigated the effects of overexpression of p116Rip and its N-terminal region on cell  
morphology and cytoskeletal organisation in NIH3T3 cells. To this end, we used HA-tagged 
p116Rip and a p116Rip-GFP fusion protein (its direct binding to F-actin was confirmed; Fig. 
6A). Contrary to expectations raised by the actin-bundling studies, overexpression of p116Rip 
in NIH3T3 cells resulted in loss of stress fibres and outgrowth of long dendrite-like processes 
(Fig. 6B). This phenotype was observed with wild-type p116Rip, Myc-, HA- and p116Rip-GFP 
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(Fig. 6, B and C, and results not shown). Less than 10% of the p116Rip-transfected NIH3T3 
cells contained stress fibres, compared with >60% of the GFP-expressing control cells (Fig. 
6D). LPA stimulation of NIH3T3 cells leads to rapid RhoA-mediated cell contraction (albeit 
less dramatic than in N1E-115 cells). However, no contractile response to LPA was seen in 
the p116Rip-overexpressing NIH3T3 cells, similar to what we previously observed in p116Rip-
overexpressing N1E-115 cells (13). Loss of stress fibres was already detectable at 6 to 8 h 
after transfection, whereas process extension appeared at later time points (>12–16 h, when 
p116Rip levels were more elevated). 
 
Figure 5. p116Rip induces bundles of F-actin 
Electron micrographs showing negatively 
stained preparations of actin filaments 
incubated with GST (a), bundles formed by 
incubating F-actin with α-actinin (b), p116Rip-
GST (c), p116Rip-Myc (d), NT-p116Rip (e), 
and CT-p116Rip (f). Scale bars, 50 nm. 
 
 
Expression of the actin-binding region (HA-NT-p116Rip) in NIH3T3 cells led to the 
same dramatic loss of stress fibres and induction of dendrite-like extensions. In contrast, 
cells expressing the C-terminal domain only (HA-CT-p116Rip) displayed a normal stress fiber 
pattern (Fig. 7, A and B). Thus, the NT region of p116Rip is necessary and sufficient for 








cells containing stress fibres. At 
least 100 cells with similar 
expression levels of p116Rip or 
control constructs were counted for 
each experiment. Cells containing 
four or more stress fibres were 
scored as "cells with stress fibres." 
To eliminate observer bias, cells 
were counted using a "blind" setup. 
Data are the means (± S.D.) of 
three independent experiments. 
Figure 6. Expression of full-length 
Ripp116  or the isolated actin-binding 
domain induces a dendritic 
morphology and loss of stress 
fibres in NIH3T3 cells 
(a) Binding of transfected p116Rip to 
F-actin. COS-7 cells were 
transfected with the indicated 
plasmids. Supernatant aliquots 
were pelleted in either the 
presence (centre blot) or absence 
(top blot) of filamentous actin. 
Cosedimentation of the proteins 
with F-actin was tested by SDS-
PAGE and Western blot using 
polyclonal anti-p116Rip and anti-
GFP antibodies. Actin was 
detected by PonceauS staining. 
Transfected FLp116Rip (GFP 
fusion, Myc-, or HA-tagged), but 
not GFP alone, is seen to 
cosediment with F-actin in vitro. (b, 
and c) NIH3T3 fibroblasts were 
transfected with an HA-tagged 
p116Rip construct, a p116Rip-GFP 
fusion construct, or GFP alone. 
Cells were fixed and stained 24 h 
after transfection. Cells expressing 
GFP, p116Rip-GFP, or HA-
FLp116Rip were visualised by 
immunofluorescence microscopy 
using either GFP fluorescence or 
an anti-HA antibody (left). Centre 
column shows staining with 
rhodamine-conjugated phalloidin 
(red in the merged pictures). Note 
the loss of stress fibres and the 
dendritic-like morphology of cells 
that overexpress HA-FLp116Rip or 
p116Rip-GFP, compared with GFP-
expressing control cells. (d) 
Quantitative analysis of transf cted 
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Finally, we examined the cytoskeletal response of
cells to platelet-derived growth factor (PDGF), which is a 
lammelipodia formation and membrane ruffling. PDGF 
formation in the control cells but not in the p116Rip-GFP-ex
We conclude that although p116Rip has actin-bundling ac
p116Rip in fibroblasts and neuronal cells disrupts F-actin assembly and thereby interferes 







ink et al., 2001).  
 fact, we have since found that p116Rip is unlikely to be a direct binding partner of RhoA 
upple entary data). In the present study, we provide the first insights into the function of 
p116Rip We show here that p116Rip is an F-actin-binding protein that has bundling activity in 
vitro, with the actin-binding domain residing in the N-terminal region (aa 1–212; construct ∆6-
p116Rip Fig. 4C). This conclusion is based on the following observations: 1) p116Rip and NT-
p116Rip ssociate with actomyosin complexes in vivo; 2), the N-terminal region of p116Rip, 
terminal half, cosediments with F-actin in vitro; and 3), purified full-length 
116  and NT-p116Rip induce the assembly of actin filaments into thick bundles in vitro. In 
ial nuclear localisation 
 p116Rip-overexpressing NIH3T3 
potent inducer of Rac-mediated 
induced prominent lamellipodia 
pressing cells (Fig. 8, A and B). 




We originally isolated p116Rip as a RhoA-interacting protein in a yeast two-hybrid screen 
(Tang and Janmey, 1996; Gebbink et al., 1997). Binding to activated RhoA was relatively 
weak, however, and our initial conclusion that p116Rip interacts directly with RhoA in 






but not its C-
Ripp
addition, we show that endogenous p116Rip localises to dynamic F- actin-rich structures that 
are normally under the control of Rho family GTPases, notably along stress fibres, in cortical 
microfilaments as well as in filopodia and lamellipodia. Furthermore, p116Rip is also detected 
in the nucleus, consistent with p116Rip containing several potent
signals (between residues 43–587; not shown). There is growing evidence for the presence 
of actin and actin-binding proteins in the nucleus, but very little is still known about their 
importance for normal cell function (Rando et al., 2000). One challenge for future studies is 
to determine how nuclear targeting of p116Rip is normally regulated. 
The N-terminal region p116Rip shows no obvious sequence similarity to known F-
actin-binding proteins. Therefore, p116Rip does not classify as a member of the superfamily 
of actin-binding proteins that includes α-actinin/spectrin members, plectin, filamin, and 
dystrophin (McCann and Craig, 1997; Lappalainen et al., 1998; Van Troys et al., 1999). At 
least three distinct mechanisms could account for the actin-bundling activity of NT-p116Rip. 
One possibility would be that NT-p116Rip is able to dimerise and thereby induces actin 
bundling. However, using transfected COS cells, we did not detect an interaction between 
NT-p116Rip and full-length p116Rip (results not shown), which argues against the possibility 
that the NT domain can form dimers. The second possibility is that NT-p116Rip might bundle 
F-actin through the polycationic KKKRK motif (residues 157–161), just after the first PH 
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domain (Tang and Janmey, 1996). However, mutational analysis reveals that neither the first 
PH domain nor the cationic motif is sufficient for F-actin binding (Fig. 4C). A third possibility 
is that 
 is precedent for actin cross-linking proteins to cause F-actin disassembly in 
vivo. In
pe. 
NT-p116Rip may harbor two actin-binding domains, each of which binds a separate 
actin filament; as yet, we have no evidence for or against this notion. Further studies are 
required to identify the N-terminal sequence motifs in p116Rip that determine F-actin binding 
and bundling. 
Contrary to what one would expect for a protein with actin-bundling activity, 
overexpression of p116Rip in NIH3T3 cells causes loss of stress fibres and produces a 
dendrite-like morphology. This phenotype, which is reminiscent of cells expressing 
dominant-negative RhoA (Jalink et al., 1994; Brouns et al., 2001) requires the N-terminal 
actin-binding domain of p116Rip but not the C-terminal coiled-coil region. The importance of 
the N terminus in determining cytoskeletal architecture can also be inferred from the 
observation that overexpressed p116Rip causes cell flattening in N1E-115 cells, whereas an 
N-terminally truncated version does not (Gebbink et al., 1997). Loss of stress fibres and 
other actin-rich structures is a common feature of overexpressed actin-monomer (G-actin) 
sequestering proteins (Vartiainen et al., 2000; Lee et al., 2001; Mattila et al., 2003), but our 
efforts to test whether NT-p116Rip can bind G-actin yielded negative results (not shown). 
However, there
 particular, overexpression of the actin-binding region of neurabin, an F-actin cross-
linking protein, causes collapse of stress fibres and promotes filopodial outgrowth, 
apparently by recruiting protein phosphatase I to F-actin-rich structures (Oliver et al., 2002). 
Furthermore, overexpression of villin, a protein that can bundle, cap, nucleate, or sever actin 
in vitro, results in the disappearance of stress fibres and enhanced microvilli elongation, a 
phenotype that strictly correlates with the actin-bundling activity of villin (Friederich et al., 
1999). 
Overexpressed p116Rip not only induces an inactive RhoA phenotype but also 
interferes with PDGF-induced lamellipodia formation, which is a typical Rac-mediated 
response. The present findings lead us to suggest that, rather than being a negative 
regulator of Rho/Rac, p116Rip can destabilise F-actin-rich structures by competing with and 
displacing other actin-cross-linking proteins. An alternative or additional possibility is that 
p116Rip may recruit regulatory proteins that disassemble the F-actin network (such as actin-
severing proteins or protein phosphatases; see (Oliver et al., 2002)). As for the displacement 
model, the neuronal F-actin-binding protein drebrin induces the formation of highly branched 
processes, similar to that observed with p116Rip. It does so by interfering with the actin 
binding and bundling activities of fascin, α-actinin, and tropomyosin (Ishikawa et al., 1994; 
Sasaki et al., 1996). A similar mechanism might underlie the p116Rip overexpression 
phenoty
Finally, we note that a recently identified actin-binding protein named Tara (593 
residues) shows a high degree of similarity to p116Rip (46% overall amino acid identity 
(Seipel et al., 2001)). In common with p116Rip, Tara contains an N-terminal PH domain and a 
C-terminal coiled-coil region, but it lacks the N-terminal actin-binding region of p116Rip. No 
actin cross-linking activity has been reported for Tara until now; nevertheless, 
overexpression of Tara in HeLa cells leads to enhanced formation of stress fibres and 
cortical F-actin (Seipel et al., 2001). Thus, despite their structural similarities, p116Rip and 




 contractility of the actomyosin-based cytoskeleton. Further insight into the 
physiol
 
Figure 7. Loss of stress fibres induced by p116Rip and its actin-binding domain 
(a) NIH3T3 cells expressing the deletion constructs were analysed for the presence of stress fibres. 
At least 100 cells with similar expression levels of HA-NT-p116Rip or HA-CT-p116Rip were counted for 
each experiment. Cells containing four or more stress fibres were scored as "cells with stress fibres". 
To eliminate observer bias, cells were counted by using a blind setup. Data are the means (± S.D.) of 
three independent experiments. (b) NIH3T3 cells were transfected with the indicated deletion 
mutants, fixed, and immunostained 24 h after transfection. Cells expressing p116Rip deletion mutants 
were visualised by immunofluorescence using anti-HA antibody (left). Centre column shows staining 
with rhodamine-conjugated phalloidin (red in the merged pictures). 
 
In conclusion, our studies specify p116Rip as a novel F-actin-binding protein with 
bundling activity in vitro and demonstrate that p116Rip can affect, directly or indirectly, the 
integrity and
ogical role of p116Rip in cytoskeletal regulation will rely on the identification of 
additional binding partners of p116Rip as well as on interference approaches by using RNA  






Figure 8. p116Rip overexpression inhibits 
lamellipodia formation by PDGF 
(a) NIH3T3 cells were transfected with GFP or 
p116Rip-GFP constructs (left). Cells were serum-
starved for 7 h before stimulation with PDGF (25 
ng/ml). Cells were fixed and immunostained 24 h 
after transfection. Centre column shows staining 
with rhodamine-conjugated phalloidin (red in the 
merged pictures). (b) Transfected cells were 
analysed for the presence of lamellipodia. At least 
100 cells expressing p116Rip or control constructs 
were counted for each experiment. Data are the 
means ± S.D. of three independent experiments. 
 
cells after the transfection 
a 
Materials and Methods 
 
Cell culture and transfection 
N1E-115 and COS-7 cells were grown in Dulbecco's modified Eagle's medium containing 7.5% fetal 
calf serum. NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium containing 10% 
newborn calf serum. N1E-115 cells were transiently transfected using the calcium phosphate 
precipitation method described previously (Kranenburg et al., 1995). NIH3T3 cells were transfected 
using Lipo-fectAMINE Plus (Invitrogen), and serum was added to the 
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procedure as described by the manufacturer. COS-7 cells were transfected by the DEAE-dextran 
method as described previously (Zondag et al., 1996). 
 
Expression constructs 
Generation of full-length (FL) pcDNA3-p116Rip (aa 1–1024), pcDNA3-HA-CTp116Rip (aa 545–1024), 
pcDNA3-HA-RBDp116Rip (aa 545–823), and prp261-RBDp116Rip (aa 545–823) has been described 
previously (Gebbink et al., 1997). pcDNA3-HA-FLp116Rip was engineered by use of a polylinker 
created by annealing primers 5'-ggatggcttacccatacgatgttccagattacgcgtgc-3' and 5'-
acgcgtaatctggaacatcgtatgggtaagccatccgc-3' encoding the HA-tag sequence and a SacII restriction 
site. The polylinker was ligated into pcDNA3-FLp116Rip via the SacII site. pcDNA3-HA-NTp116Rip (aa 
1–382) and GST-NT were generated by PCR using primers 5'-cggggtaccacatgtcggcggccaaggaa-3' 
(forward) and 5'-cggaattccggcgtcatggaggattctgt-3' (reverse) for NT. GST-CT was generated from 
pcDNA3-HA-CTp116Rip. GST-∆5 (aa 1–152), GST-∆6 (aa 1–212), GST-∆7 (aa 43–152), GST-∆8 (aa 
43–212); GST-∆9 (aa 212–390) were generated similarly by PCR using specific primers. The PCR 
products were digested with KpNI-EcoRI and ligated into pcDNA3-HA and pRP265, a derivative of 
pGEX-1N. FLp116Rip-peGFPN1-was constructed by ligation of a HindIII-ScaI fragment out of pcDNA3-
FLp116Rip and a PCR fragment using primers 5'-cagagcagtactcccaaaagtgcctgg-3' (forward) and 5'-
cgcggtaccagtcgacagaattcgttatcccatgagac-3' (reverse), encoding ScaI and Asp718 restriction sites, 
into peGFPN1 (Clontech). pMT2sm-FLp116Rip-GST was generated by ligation of a NotI-ScaI fragment 
of pcDNA3-FLp116Rip and a PCR fragment using primers 5'-cagagcagtactcccaaaagtgcctgg-3' 
(forward) and 5'-cggggtaccggaattcgttatcccatgagacctg-3' (reverse), encoding ScaI and Asp718 
restriction sites, into pMT2sm-GST. pMT2sm-FLp116Rip-myc was generated by cloning FLp116Rip-myc 
into pMT2sm. Sequence of all constructs was verified by automated sequencing. 
 
Solubility assay 
Cells were lysed in ice-cold lysis buffer (0.1% Triton X-100, 50 mM Tris, pH 7.4, 150 mM NaCl, and 1 
mM EDTA, supplemented with protease inhibitors) and were left on ice for 15 min. Lysates were 
centrifuged for 30 min (13,000 rpm; Eppendorf table centrifuge, 4 °C). Pellet and supernatant fractions 
were collected, dissolved in sample buffer, and su
Western blotting using the polyclonal anti-p116Rip a
 
Expression and purification of recombinant fusion p
The E. coli strains BL21 or DH5α were transforme
∆5, GST-∆6, GST∆7, GST∆8, GST∆9, or GST, 
inoculate Luria broth/ampicillin. Cultures were gr
overnight to induce expression of the fusion prote
and 0.6. Bacteria were harvested by centrifugatio
mM Tris-HCl, pH 7.6, 50 mM NaCl, 5 mM MgCl2, 1
fluoride), and lysed by sonification followed y t
cleared by centrifugation at 4000 x g, and r  supernatants were incuba glutathione-
Sepharose 4B beads (Amersham Biosciences). Beads with affinity-bound proteins were washed five 
und proteins were eluted with 50 mM Tris-HCl, pH 8.0, containing 10 
cases, GST was cleaved off by incubating beads with affinity-bound 
ham Biosciences) according to manufacturer's protocol. 
Rip Rip
bjected to SDS-PAGE. Proteins were detected by 
ntibody (1:1000 dilution). 
roteins 
d with plasmids encoding GST-NT, GST-CT, GST-
respectively. Colonies were obtained and used to 
own and isopropyl β-D-thiogalactoside was added 
ins when the cultures reached an OD between 0.4 
n at 4000 x g, resuspended in cold lysis buffer (50 
 mM dithiothreitol, and 1 mM phenylmethylsulfonyl 




times with lysis buffer, and bo
M reduced glutathione. In some m
proteins with thrombin (Amers
Purified full-length p116  fused to GST or purified full-length p116  fused to Myc were 
obtained by transfection of COS-7 cells with the constructs pMT2sm-FLp116Rip-GST and pMT2sm-
FLp116Rip-myc, respectively. Cells were lysed in ice-cold lysis buffer (1% Nonidet P-40, 50 mM Tris, 
pH 7.4, 200 mM NaCl, 2.5 mM MgCl2, and 10% glycerol, supplemented with protease inhibitors). 
Lysates were cleared by centrifugation (13,000 rpm; 10 min). Further purification of the full-length 
GST fusion proteins occurred in the same manner as the purification of GST fusion proteins produced 
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in bacteria. FLp116Rip-myc fusion protein was purified using a column of monoclonal myc antibodies 
(9E10) chemically cross-linked to protein G-Sepharose beads (Amersham Biosciences). The protein 
as eluted off with 0.1 M glycine, pH 2.5, and fractions were collected in tubes containing 0.1 volume 
0, to make an end pH of 7.0. Eluted proteins were subjected to SDS-PAGE, 
e resolved by SDS-
PAGE and detected by either Coomassie Blue staining or by Western blot analysis using anti-p116Rip 
FP rabbit polyclonal antibodies (van Ham et al., 1997), or an anti-actin mouse 
oomassie Blue staining 
nd were scanned and quantified using the software program TINA. The amount of p116Rip bound to 
ctangular hyperbola using Prism (ver. 3; 
N1E-11
w
of 1 M Tris-HCl, pH 8.
followed by protein staining with Coomassie Blue to estimate the purity and concentration of the 
proteins in the fractions. Some of the proteins were concentrated using Centricon 10-kDa cutoff 
devices (Millipore). Protein concentration was also determined by the Bradford method using BSA as 
a standard. Purified proteins were stored in aliquots at -80 °C in 10% glycerol. 
 
F-actin cosedimentation assay 
COS-7 cells were transfected with the indicated expression vectors and lysed for 48 h after 
transfection in ice-cold lysis buffer (1% Nonidet P-40, 50 mM Tris, pH 7.4, 200 mM NaCl, 2.5 mM 
MgCl2, and 10% glycerol, supplemented with protease inhibitors). Lysates were cleared by 
centrifugation (13,000 rpm; 10 min) and supernatant aliquots were run out on SDS-PAGE gels to 
check for expression (data not shown). 10-µl aliquots were used in the in vitro actin-binding assay.  
F-actin cosedimentation assays were performed according to the manufacturer's protocol 
(Cytoskeleton, Denver, CO). Briefly, prespun aliquots of COS-7 cell lysates (100,000 x g, 30 min) or 
purified proteins GST-NTp116Rip, GST, FLp116Rip-GST, BSA, α-actinin (Cytoskeleton), or GST-
∆5p116Rip; GST-∆6p116Rip; GST-∆7p116Rip; GST-∆8p116Rip; GST-∆9p116Rip were incubated for 1 h at 
room temperature with 40 µg of pure actin filaments. The final concentration of F-actin was 18 µM. 
Filaments were subsequently pelleted by centrifugation 100,000 x g (Beckman airfuge). As a control 
for actin-independent sedimentation, the various proteins were also centrifuged under conditions in 
which filamentous actin was omitted from the mix. Cosedimenting proteins wer
antibodies, anti-G
monoclonal antibody (Mab 1501R; Chemicon).  
For quantitative analysis, a fixed concentration of FLp116Rip-GST (1 µM) was mixed with 
increasing amounts of F-actin (0–3.5 µM) in polymerisation buffer and incubated at room temperature 
for 30 min. Proteins were centrifuged as above and total pellets and supernatants were loaded 
separately on SDS-polyacrylamide gels. Protein bands were detected by C
a
different concentrations of F-actin was fit to a single re
GraphPad Software, San Diego, CA). In all cases, entire pellet and supernatant fractions were loaded 
separately on SDS-polyacrylamide gels and detected by either Coomassie Blue staining or by 
Western blot (above). 
 
Electron microscopy 
To test for bundling activity, actin filaments (5 µM) were incubated for 30 min with purified proteins 
GST, α-actinin (both 2 µM), FL-p116Rip (0.5 µM), NT-p116Rip (0.5 µM), and CT-p116Rip (0.5 µM) at 
room temperature. Samples were absorbed on to glow-discharged carbon-coated formvar film on a 




5 cells were incubated in methionine/cysteine-free media for 30 min and labeled for 4 h with 
medium containing [35S]methionine/cysteine (200 µCi/ml; Amersham Biosciences). Labeled medium 
was aspirated and cells were washed once in ice-cold PBS. Cells were scraped in ice-cold lysis buffer 
(1% Nonidet P-40, 50 mM Tris pH 7.4, 200 mM NaCl, 2.5 mM MgCl2, and 10% glycerol, 
supplemented with protease inhibitors). Lysates were cleared by centrifugation (13,000 rpm; 10 min) 
and supernatants were tumbled with protein A-Sepharose beads precoupled to either preimmune 
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rabbit serum, anti-p116Rip antibodies (Gebbink et al., 1997), or anti-myosin IIA antibodies (BTI, 
Oklahoma City, OK) for 1h at 4 °C. GST pull-down assays were performed with 20 µl of GSH-
Sepharose beads loaded with 20 µg of either GST alone or the GST-NT-fusion protein containing the 
isolated actin-binding domain. Beads were washed five times in ice-cold lysis buffer and resolved by 
SDS-PAGE. Proteins were detected by autoradiography. In some cases the gels were blotted and 
further analysed by Western blotting to assess the identity of labeled proteins using the polyclonal 
anti-p116Rip antibody (1:1000 dilution) and anti-myosin II antibodies (1:500 dilution). 
 
Antibodies and Confocal Microscopy 
 against GST-RBD (amino acids 545–823) has been described 
Ayscough
riederich,E., Vancompernolle,K., Louvard,D., and Vandekerckhove,J. (1999). Villin function in the organization of the actin 
f in vivo effects to its biochemical activities in vitro. J. Biol. Chem. 274, 26751-26760. 
 1337. 
.D. (2001). Regulation of actin filament network formation through ARP2/3 complex: activation by a 
The FRA58 antibody directed
previously (Gebbink et al., 1997). N1E-115 cells and NIH3T3 cells were grown on gelatin-coated glass 
coverslips in six-well plates. N1E-115 cells were serum-starved overnight and NIH3T3 cells for 7 h. 
Cells were fixed 24 h after transfection in 3.7% formaldehyde in PBS for 10 min, permeabilised (0.1% 
Triton X-100/PBS; 2 min), blocked (1% BSA/PBS; 30 min), and incubated with primary antibodies 
(FRA58 preimmune serum, polyclonal FRA58 anti-p116Rip, 3F10 anti-HA rat monoclonal antibodies 
(Roche; 1 h). Subsequently, cells were washed and incubated with secondary antibodies (Goat-anti-
rabbit-fluorescein isothiocyanate (DAKO) and Goat-anti-rat-fluorescein isothiocyanate (Rockland); 30 
min)) together with rhodamine-conjugated phalloidin (Molecular Probes). Coverslips were mounted in 
Vectashield and analysed using a Leica TCS-NT confocal microscope. 
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Figure 2. No detectable endogenous interaction between RhoA and p116Rip
(a) GST pull-downs were performed in N1E-115 lysates using GST-RhoA fusion proteins loaded 
with either GDP or GTP, and precipitates were subjected to SDS-PAGE. Blots were incubated 
with α-RhoA, α-p116Rip, or α-ROCK. Total cell lysates (TL) were analysed for ROCK and p116Rip 
expression (left panel). Whereas endogenous ROCK associates with Rho in a GTP-dependent 
manner, p116Rip does not co-precipitate with either RhoA-GDP or RhoA-GTP. (b) GST-RhoA or 
GST fusion proteins (arrows) were incubated with N1E-115 lysates (left panel) or lysis buffer (no 
lysate, right panel). Precipitates were subjected to SDS-PAGE and blots were incubated with α-
p116Rip or α-GST. TL analysed for p116Rip expression are shown (arrow head, middle panel). 
This figure shows that the two proteins that are immunoreactive with the p116Rip antibodies 





Thus, despite the specific RhoA-p116Rip interaction in vitro and in yeast two-hybrid analysis, 
the in vivo existence of a p116Rip-RhoA complex remains ambiguous. Also in intact cells 
p116Rip and RhoA do not obviously co-localise, as determined by confocal analysis (Chapter 
2). There may be several reasons for the inability to detect an endogenous interaction 
between p116Rip and RhoA. In addition to the possibility that the two proteins just do not 
interact in an in vivo situation, the interaction might be too transient to be detected by co-
precipitation or pull-down assays. The RhoA binding domain of p116Rip is not homologous to 
that of other Rho-binding proteins and SMART, Pfam, or MOTIF search programs do not 
identify a consensus Rho-binding domain in p116Rip. Studying the affinity of the RhoA-
p116Rip interaction might be helpful to shed more light on the nature of this interaction and 
the likelihood of an endogenous p116Rip-RhoA complex. As yet, we conclude that p116Rip is 































p116Rip targets myosin phosphatase to the actin cytoskeleton and 
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Activation of the RhoA-Rho kinase (ROCK) pathway stimulates actomyosin-driven 
contractility in many cell systems, largely through ROCK-mediated inhibition of myosin-II 
light-chain phosphatase. In neuronal cells, the RhoA-ROCK-actomyosin pathway signals cell 
rounding, growth cone collapse and neurite retraction; conversely, inhibition of RhoA/ROCK 
promotes cell spreading and neurite outgrowth. The actin-binding protein p116Rip, whose N-
terminal region bundles F-actin in vitro, has been implicated in Rho-dependent neurite 
remodelling; however, its function is largely unknown. Here we show that p116Rip, through its 
C-terminal coiled-coil domain, interacts directly with the C-terminal leucine zipper of the 
regulatory myosin-binding subunits of myosin-II phosphatase, MBS85 and MBS130. RNAi-
induced knockdown of p116Rip inhibits cell spreading and neurite outgrowth in response to 
extracellular cues, without interfering with the regulation of myosin light-chain 
phosphorylation. We conclude that p116Rip is essential for neurite outgrowth and may act as 





Small GTP-binding proteins of the Rho family, notably RhoA, Rac and Cdc42, are key 
regulators of the actin cytoskeleton in response to extracellular cues (Etienne-Manneville 
and Hall, 2002). In particular, RhoA regulates actomyosin-driven contractile events and 
morphological changes in many cell types, including those of the nervous system (Hall, 
1998; Kaibuchi et al., 1999; Luo, 2000). It does so primarily by stimulating the activity of 
Rho-kinase (ROCK), which phosphorylates the regulatory myosin-binding subunit (MBS) of 
myosin light chain (MLC) phosphatase. When phosphorylated by ROCK, MBS inhibits the 
activity of MLC phosphatase and thereby promotes MLC phosphorylation and actomyosin 
contractility (Kimura et al., 1996; Kawano et al., 1999). In neuronal cells, activation of the 
RhoA-ROCK-actomoysin pathway is necessary and sufficient to induce growth cone 
collapse, retraction of developing neurites and transient rounding of the cell body in 
response to certain receptor agonists, such as lysophosphatidic acid (LPA), thrombin and 
sphingosine-1-phosphate (Jalink et al., 1994; Postma et al., 1996; Kozma et al., 1997; 
Amano et al., 1998; Hirose et al., 1998; Bito et al., 2000). Conversely, inactivation of the 
RhoA-ROCK pathway, using pharmacological inhibitors or dominant-negative constructs, is 
sufficient to promote neurite outgrowth and growth cone motility (Jalink et al., 1994; Kozma 
et al., 1997; Hirose et al., 1998; Bito et al., 2000). From these studies, it has emerged that 
RhoA-actin pathways are fundamental to neurite remodeling, guidance and branching not 
only in neuronal cell lines but also in primary neurons (Luo, 2000; Luo, 2002). Many 
questions remain, however, as it remains unclear how components of Rho signalling 
pathways are compartmentalised and assembled into functional signalling modules, and how 
the specificity of signal transduction is controlled. 
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Various actin-associated proteins participate in regulating cytoskeletal dynamics 
downstream of Rho GTPases, with some proteins arranging actin into higher-order 
structures and others controlling actin remodeling in response to physiological stimuli 
(Ayscough, 1998; Bamburg, 1999; Borisy and Svitkina, 2000; Wear et al., 2000; Higgs and 
Pollard, 2001; Da Silva et al., 2003). We previously identified a ubiquitously expressed 
protein of predicted size 116 kDa, named p116Rip, which binds relatively weakly to 
constitutively active RhoA(V14) in a yeast two-hybrid assay (Gebbink et al., 1997). The 
p116Rip sequence reveals several protein interaction domains, including two PH domains, 
two proline-rich stretches and a C-terminal coiled-coil domain; it lacks any known catalytic 
motif. When overexpressed in N1E-115 neuroblastoma cells, p116Rip promotes cell flattening 
and neurite extension and inhibits LPA-induced neurite retraction, reminiscent of what is 
observed after RhoA inactivation using dominant-negative RhoA or the Rho-inactivating C3 
toxin (Gebbink et al., 1997). This led us to hypothesize that p116Rip may negatively regulate 
RhoA signalling. More recently, however, we found that p116Rip, rather than directly binding 
to RhoA (Gebbink et al., 2001), interacts through its N-terminal region with F-actin and 
colocalises with dynamic actomyosin-rich structures, including stress fibers and cortical 
microfilaments in filopodia and lamellipodia (Mulder et al., 2003). Furthermore, we found that 
p116Rip induces bundling of F-actin in vitro, with the bundling activity residing in the N-
terminal region. Despite being an actin-bundling protein, overexpression of p116Rip or its N-
terminal actin-binding domain in neuroblastoma cells disrupts the actin cytoskeleton and 
thereby inhibits actomyosin contractility to promote neurite outgrowth (Mulder et al., 2003). 
Thus, p116Rip is an actin-binding protein that may act as a scaffold for multiple protein 
interactions involved in neurite remodeling.  
To understand the normal biological function of p116Rip in neuritogenesis, we set out 
to identify binding partners of the C-terminal domain of p116Rip and to undertake a loss-of- 
function analysis using RNA interference (RNAi). We report here that the coiled-coil domain 
of p116Rip interacts directly with the regulatory myosin-binding subunits of MLC 
phosphatase, MBS85 and MBS130. Furthermore, our RNAi-studies show that p116Rip-
deficient cells fail to undergo neurite outgrowth in response to various extracellular cues 
(RhoA/ROCK inhibition, intracellular cAMP elevation, or growth factor deprivation), while the 
regulation of MLC phosphorylation remains intact. Thus, p116Rip is an essential component 





Identification of myosin phosphatase targeting subunits, MBS85 and MBS130, as binding 
partners of p116Rip
We previously reported that the N-terminal region of p116Rip (residues 1-382) binds tightly to 
F-actin (Kd approx. 0.5 µM), shows F-actin-bundling activity in vitro, and dictates the 
subcellular localisation of p116Rip to dynamic actin-rich structures such as stress fibers and 
cortical microfilaments (Mulder et al., 2003). To identify additional binding partners of 
p116Rip, we performed a yeast two-hybrid screen with the C-terminal part of p116Rip (aa 391-
1024) as bait and a human testis cDNA library as prey. We detected a strong interaction with 





Figure 1. Yeast two-hybrid interaction between p116Rip and MBS85 
(a) MBS85 was identified by screening a human testis cDNA library using the C-terminal part of 
p116Rip as bait (p116Rip-∆N). Binding of the α-helical leucine zipper of MBS85 to the C-terminus of 
p116Rip was confirmed in retransformation assays, in which clones became positive for β-
galactosidase activity within 1 hr. Yeast cells (Y190) were transformed with Mb2a encoding the 
GAL4 binding domain fused with the C-terminus of p116Rip and VP16 encoding the GAL4 activation 
domain fused with the C-terminus of MBS85 and screened for β-galactosidase activity (+). Empty 
vector controls are indicated. (b) Schematic representation of the interacting domains (bait-prey) in 
p116Rip and MBS85. Abbreviations: PH, pleckstrin homology domain; ANK, ankyrin repeats; Coil, 
coiled-coil domain; αLZ, α-helical leucine zipper domain. Numbers refer to amino acid residues. 
 
subunit p85 (MBS85) (Fig. 1A). MBS85 is structurally and functionally related to its better-
known and more widespread family member MBS130 (Tan et al., 2001), with both proteins 
containing N-terminal ankyrin repeats and an α-helical leucine zipper at the C-terminus. 
MBS85 is highly expressed in brain and heart, but unlike MBS130, not in smooth muscle 
(Tan et al., 2001). Through their N-terminal region, MBS85 and MBS130 bind to the catalytic 
subunit, protein phosphatase-I (PP1δ; 37-kDa), and thereby regulate phosphatase activity 
toward the myosin-II light-chain (MLC). MBS binds to the active, GTP-bound form of RhoA 
and is a direct target of ROCK (Kimura et al., 1996). MBS phosphorylation by ROCK results 
in inhibition of phosphatase activity with a consequent increase in MLC phosphorylation and 
actomyosin contractility. 
A schematic representation of the two-hybrid interaction between the C-terminal 
parts of p116Rip and MBS85 is shown in Fig. 1B. Given the high similarity between MBS85 
and MBS130 in their α-helical leucine repeats (66% at the amino acid level) (Tan et al., 






Figure 2. The coiled-coil domain
of p116Rip interacts with the C-
terminal leucine zipper of MBS85
and MBS130 in mammalian cells
(a, b) COS-7 cells were
transfected with plasmids
encoding FLAG-MBS85 or Myc-
MBS130 and the indicated HA-
tagged p116Rip truncation
mutants or HA-coilp190RhoGEF.
Total cell lysates (TL) were
analysed for MBS85 and
MBS130 expression (upper
panels). Immunoprecipitation (IP)
of HA-tagged proteins and co-
precipitation of MBS85 or
MBS130 was analysed by
immunoblotting (IB) using α-HA,
α-FLAG, and α-Myc antibodies.
(c) Analysis of the interaction
between the coiled-coil domain of
p116Rip and the leucine zipper of
MBS (MBS85 and MBS130), as
determined in COS-7 cells; +
denotes interaction with MBS.
NT, N-terminal region; CT, C-
terminal region; RBD, ‘Rho-
binding’ domain (as defined in






Figure 3. (Iso)leucine residues in the coiled-coil of p116Rip mediate binding to the leucine zippers 
of MBS85 and MBS130 
Representation of residues 823-930 of the coiled-coil domain of p116Rip. Leucine zipper-like 
motifs are underlined. (Iso)leucines in bold were mutated to proline by site-directed mutagenesis. 
COS-7 cells were co-transfected with plasmids encoding either FLAG-MBS85 or Myc-MBS130 
and indicated HA-tagged plasmids encoding p116Rip (iso)leucine mutants or an empty HA-tagged 
plasmid as control. Total cell lysates (TL) analysed for MBS85 and MBS130 expression are 
shown (upper panels in both figures). Immunoprecipitation (IP) of HA-tagged proteins and co-
precipitation of MBS85 or MBS130 was analysed by immunoblotting (IB) using α-HA, α-FLAG, 
and α-Myc antibodies. 
 
We found that epitope-tagged forms of MBS85 and MBS130 both co-precipitate with HA-
tagged p116Rip (Fig. 2A, B), indicating that the p116Rip-MBS85/130 interaction occurs in vivo. 
To map the region in p116Rip that mediates MBS binding, we generated HA-tagged 
truncation mutants of the C-terminal part of p116Rip and expressed them in COS cells. As a 
negative control, we used the C-terminal coiled-coil domain of an unrelated protein, the Rho-
specific exchange factor p190RhoGEF (van Horck et al., 2001). All p116Rip truncation 
mutants containing the coiled-coil domain were found to precipitate both MBS130 and 
MBS85 from COS cell lysates (Fig. 2A-C). No MBS interaction was detected with a truncated 
coiled-coil mutant (‘RBD’; aa 545-823) or with the isolated N-terminal part of p116Rip (NT; aa 
1-382), nor with the coiled-coil domain of p190RhoGEF (Fig. 2A, B). These results indicate 
that the coiled-coil region of p116Rip (aa 545-1024) interacts specifically with the α-helical 
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leucine zippers of MBS85 and MBS130, and that the MBS-binding region of p116Rip is 
located within the C-terminal half of the coiled-coil domain (aa 823-1024; Fig. 2C). 
Leucine zippers are commonly regarded as regular coiled-coil structures (O'Shea et 
al., 1989), in which the (iso)leucine repeats form a hydrophobic region where side-chain 
interactions mediate protein-protein interaction; mutagenesis of selected (iso)leucine 
residues (to alanine, valine, or proline) abrogates the interaction (Turner and Tjian, 1989; Hu 
et al., 1990). To determine whether leucine-isoleucine motifs in the coiled-coil of p116Rip are 
essential for binding to the MBS leucine zipper, we replaced residues Leu(857), Leu(950) 
and Ile(919) in p116Rip with Pro residues (Fig. 3). Protein-protein interactions were examined 
by co-expression of these p116Rip mutants with either MBS85 or MBS130. As shown in Fig. 
3, the L857P and I919P mutants, but not the L905P mutant, failed to interact with MBS85 
and MBS130. We conclude that residues Leu(857) and Ile(919) in p116Rip are critical for 
direct interaction with the leucine-zipper domains of MBS85 and MBS130. 
 
 
Figure 4. Association of endogenous p116Rip with the MLC phosphatase complex 
(a) p116Rip and MBS130 were immunoprecipitated (IP) from N1E-115 cells, and subjected to 
western blotting (IB) using MBS130 antibodies. Control lysates were incubated with protein A-
Sepharose 4B beads alone, or together with control IgG. Both isoforms of MBS130 are 
detected in p116Rip immunoprecipitates. TL denotes total cell lysates. (b) PP1δ 
immunoprecipitates (IP) from N1E-115 cells and total lysate (TL) were subjected to western 
blotting (IB) using MBS130, p116Rip, and PP1δ antibodies. MBS130 and p116Rip are seen to co-
immunoprecipitate with endogenous PP1δ. 
 
 
Endogenous interaction of p116Rip with the myosin phosphatase complex in neuronal cells 
We next examined complex formation between endogenous p116Rip and MBS130 in 
neuronal N1E-115 cells. As shown in Fig. 4, endogenous MBS130 and p116Rip were co-
immunoprecipitated from N1E-115 cell lysates using a polyclonal anti-p116Rip antibody; 
endogenous MBS85 could not be detected due to lack of antibodies. Two separate MBS130-
reactive bands are observed in p116Rip precipitates from N1E-115 cells (Fig. 4A), consistent 
with MBS130 existing in two isoforms one of which contains a central insertion (Hartshorne, 
1998). No MBS130 protein was detected in control immunoprecipitates. MBS associates 
with the catalytic subunit, PP1δ. Fig. 4B shows that p116Rip and MBS130 are both present in 
PP1δ immunoprecipitates from N1E-115 cells. We conclude that p116Rip is a component of 
the MBS-PP1δ complex in neuronal cells. 
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RNAi-induced knockdown of p116Rip inhibits neurite outgrowth 
Transient overexpression of p116Rip results in disassembly of the actin cytoskeleton and 
promotes neurite extension in N1E-115 cells (Gebbink et al., 1997; Mulder et al., 2003). 
Expression of the actin-binding region alone (NT-p116Rip) led to the same phenotype, 
whereas cells expressing the C-terminal domain alone displayed a seemingly normal F-actin 
pattern (Mulder et al., 2003). While these results suggest that the N-terminal half of p116Rip is 
critical for mediating F-actin (dis)assembly, they do not allow any conclusion about the 
normal physiological function of p116Rip. A more informative and elegant approach to 
assessing the importance of putative scaffold proteins like p116Rip is to knockdown their 
endogenous expression levels by RNA interference (RNAi). 
We used the expression vector pSUPER, which directs stable expression of small 
interfering RNAs (Brummelkamp et al., 2002a). Persistent suppression of gene expression 
by this vector allows the analysis of loss-of-function phenotypes that develop over longer 
periods of time. A green fluorescent protein (GFP)-containing construct was created that 
targets mouse p116Rip mRNA (with GFP expressed from a distinct PGK promotor), termed 
pSUPER-GFP (pS-GFP). Targeting efficacy was tested in HEK293 cells by co-transfecting 
HA-p116Rip and pS-GFPp116Rip. HA-p190RhoGEF was used as a negative control (van 
Horck et al., 2001). At 4 days after transfection, HA-p116Rip expression is knocked down by 
almost 100%, whereas HA-p190RhoGEF expression remains unaffected (Fig. 5A). The 
RNAi construct was then transfected into Neuro-2A and N1E-115 cells to study the 
phenotypic consequences of p116Rip knockdown. Immunoblot analysis confirmed effective 
knockdown of endogenous p116Rip in Neuro-2A cells (Fig. 5F). 
Neurite outgrowth (with concomitant growth arrest) can be induced by various 
treatments, including pharmacological inhibition of the RhoA-ROCK pathway, elevation of 
intracellular cAMP levels, and growth factor deprivation. While control Neuro-2A and N1E-
115 cells underwent flattening and neuritogenesis within a few hrs after serum withdrawal, 
we consistently observed that their p116Rip-deficient counterparts (pS-GFP-p116Rip-positive) 
maintained a rounded shape even after prolonged periods (>48 hrs) of serum starvation. 
Also after prolonged incubation with the membrane-permeable cAMP analogue, dibutyryl-
cAMP (db-cAMP; 4 days), the p116Rip-deficient cells (pS-GFPp116Rip-positive) remain 
rounded with little or no sign of process extensions: less than 9% of the p116Rip-depleted 
cells is capable of sending out neurites as compared to 54% of the GFP-expressing control 
cells (Fig. 5B, C). Finally, addition of the ROCK inhibitor Y-27632 resulted in rapid cell 
flattening and initiation of neurite outgrowth in both Neuro-2A and N1E-115 cells, whereas 
the p116Rip-deficient cells failed to show any morphological response to Y-27632 (Fig. 5D, 
E). Similar results were obtained with the Rho-inactivating C3-exoenzyme (our unpublished 
results). Co-expression of RNAi-resistant p116Rip (containing three silent mutations in the 
target sequence) with pS-GFPp116Rip largely restored the morphological responses (our 
unpublished results), consistent with the observed effects being specific for p116Rip loss-of-
function (although introduction of RNAi-resistant p116Rip is in fact “overexpression”).  
Together, these results indicate that p116Rip is essential for Neuro-2A and N1E-115 
cells to send out neurites in response to various extracellular cues, notably RhoA/ROCK 






Figure 5. RNAi-mediated knockdown of p116Rip prevents neurite outgrowth 
(a) pS-GFP (Control, C) or pS-GFPp116Rip plasmids were co-transfected with plasmids
encoding HA-p116Rip or HA-p190RhoGEF (van Horck et al., 2001) into HEK293 cells. Co-
transfection with pS-GFPp116Rip knocks down the expression of HA-p116Rip, but not the
expression of HA-p190RhoGEF or actin. (b) Neuro-2A and N1E-115 neuroblastoma cells
were transfected with pS-GFP or pS-GFPp116Rip plasmids. At 72 hrs after transfection,
neurite outgrowth was induced by addition of 1 mM db-cAMP. After two days, cells were
analysed by fluorescence (right panel) and phase-contrast (left panel) microscopy.
Arrowheads point to pS-GFPp116Rip-positive cells. (c) Neuro-2A cells were transfected with
pS-GFP or pS-GFPp116Rip plasmids. At 72 hrs after transfection, neurite outgrowth was
induced by addition of db-cAMP (1 mM). The number of GFP-positive, neurite-bearing
Neuro-2A cells was determined at 48 hrs after addition of db-cAMP. At least 100 GFP-







p116Rip-deficiency does not impair the regulation of MLC phosphorylation 
dependent experiments. (d) N1E-115 cells were transfected with pS-GFPp116Rip plasmids.
At 9 hrs after transfection, the ROCK inhibitor Y-27632 (10 µM) was added and subsequent
changes in cell morphology were monitored by time-lapse microscopy. Note that control
cells start to flatten and initiate neurite outgrowth within approx. 30 min. of Y-27632 addition,
whereas the p116Rip-deficent cells (arrowheads) fail to change their morphology. (e) As in
(b), the number of GFP-positive Neuro-2A or N1E-115 cells showing neurite outgrowth was
determined at 8 hrs after addition of Y-27632 (96 hrs after transfection). At least 100 cells
were counted for each experiment. Bars denote the means (± s.d.) of three independent
experiments. (f) Neuro-2A cells were transfected with the indicated plasmids, lysed 96 hrs
after transfection and analysed for p116Rip expression. pS-GFPp116Rip knocks down
endogenous p116Rip expression, taking into account a transfection efficiency of Neuro2A
cells of about 30%. 
 
Our observation that p116Rip deficiency interferes with neuritogenesis is reminiscent of what 
is observed after constitutive activation of the RhoA-ROCK pathway eventually leading to 
phosphorylation of the 20-kDa MLC. We therefore examined whether p116Rip deficiency 
affects the regulation of MLC phosphorylation. Phosphorylation of nonmuscle myosin-II on 
MLC residue Ser-19 regulates both its motor activity and filament assembly (for review see 
(Bresnick, 1999). MLC phophorylation is mediated mainly by myosin light-chain kinase with 
probably an additional but less established role for ROCK (Kawano et al., 1999; Bresnick, 
1999). The MLC phosphorylation state can be determined using a phospho-specific antibody 
that recognises MLC only when Ser-19 is phosphorylated (Matsumura et al., 1998). 
In agreement with findings by others (Amano et al., 1998), we found that differences 
in MLC phosphorylation on Ser-19 are hard to detect in neuroblastoma cells (our 
unpublished results); therefore, we turned to NIH3T3 cells. Cells were infected with control 
pS retrovirus (pRS) and pRS-p116Rip retrovirus (Brummelkamp et al., 2002b). After three 
days, cells were serum starved and then stimulated with either LPA (as a RhoA-activating 
agonist) or with calyculin A (CA), a potent inhibitor of type-I phosphatases and as such a 
strong inducer of neurite retraction. In parallel experiments, the ROCK inhibitor Y-27632 was 
added to cells maintained in serum-containing medium. As shown in Fig. 6, p116Rip 
expression levels are strongly reduced in pRS-p116Rip cells. Yet pRS control and pRS-
p116Rip cells, maintained in serum-free medium, show comparable basal levels of 
phosphorylated MLC (as detected by anti-phospho-MLC-Thr18/Ser19 antibody), while LPA 
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and calyculin A are both capable of further enhancing MLC phosphorylation (Fig. 6, lower 
panel). Neuro-2A and N1E-115 cells underwent rapid neurite retraction and cell rounding in 
response to LPA and calyculin A, whereas the rounded pRS-p116Rip cells did not show any 
further shape change in response to either stimulus. Finally, Fig. 6 shows that the ROCK 
inhibitor Y-27632 strongly reduces basal MLC phosphorylation in both control and p116Rip-
deficient cells maintained in serum-containing medium. From these results, we conclude that 
p116Rip deficiency interferes with neurite outgrowth, but leaves RhoA/ROCK regulation of 
MLC phosphorylation intact. 
 
 
Figure 6. Knockdown of p116Rip does not affect the regulation of MLC phosphorylation 
NIH3T3 cells were infected with p116Rip RNAi-encoding retrovirus (pRS- p116Rip). At 72 hrs 
after infection, cells were either serum-starved (0.1% FCS for 24 hrs) or left in serum-containing 
media. Serum-starved cells were stimulated with 2.5 µM 1-oleoyl-LPA for 10 min or with 0.1 µM 
calyculin A (CA) for 5 min (left panels). Cells that were maintained in serum-containing medium 
were incubated with 10 µM Y-27632 for 45 min (right panels). Cells were analysed for p116Rip 
expression (middle panels) and MLC phosphorylation (on Thr18/Ser19; lower panels). Actin 
expression was determined to test for equal loading. 
 
Changes in p116Rip levels affect detergent solubility of MBS 
Because p116Rip is an F-actin-bundling protein (Mulder et al., 2003), the present results 
suggest that p116Rip links the MBS-phosphatase complex to the cytoskeleton. To obtain 
biochemical evidence for this notion, we examined the association of MBS with the Triton-
insoluble fraction (loosely defined as the “cytoskeletal” fraction) as a function of p116Rip 
expression levels. Since retroviral infections of N1E-115 and Neuro-2A were unsuccessful in 
our hands, we produced p116Rip RNAi-encoding adenovirus. N1E-115 cells infected with 
either control pAS or pAS-p116Rip adenovirus were lysed and the solubility of MBS was 
determined (Mulder et al., 2003). As shown in Fig. 7 (A, B), pAS-p116Rip N1E-115 cells show 
complete knockdown of p116Rip, with all cells having a rounded morphology. In serum-
starved control cells, MBS is about 50% insoluble in 0.1% Triton. After treatment of the cells 
with LPA or CA, MBS moves to the soluble fraction (Fig. 7C, left panel), suggesting that 
MBS dissociates from the cytoskeleton. In p116Rip-deficient cells (serum-starved), however, 
80% of MBS is already found in the soluble fraction, and CA tends to shift MBS even more 




Figure 7. MBS associates with the Triton-insoluble cytoskeletal fraction in a p116Rip-dependent 
manner 
(a) N1E-115 cells were infected with control (pAS) or p116Rip-RNAi-encoding (pAS-p116Rip) 
adenovirus and lysed 96h after infection. pAS-p116Rip downregulates the expression of 
endogenous p116Rip very efficiently. (b) N1E-115 cells were infected with control (pAS) or 
p116Rip-RNAi-encoding (pAS-p116Rip) adenovirus and viewed by phase-contrast microscopy. (c, 
d) At 72 hrs after infection, cells were serum-starved. The next day, serum-starved cells were 
stimulated with 2.5 µM 1-oleoyl-LPA for 5 min or with 0.1 µM calyculin A (CA) for 4 min (left 
panels). The solubility of MBS was determined using a buffer containing 0.1% Triton-X-100, and 
subcellular fractionation was performed resulting in a supernatant (S) and pellet (P) fraction of 
control pAS or pAS-p116Rip infected N1E-115 cells. Supernatant and pellet fractions were 
immunoblotted for MBS, cortactin, and actin. (d) N1E-115 cells were transfected with GFP or 
p116Rip-GFP constructs. 48 hrs after transfection cells were serum starved overnight, stimulated 
and analysed as in c. 
 
Overexpression of p116Rip causes the opposite effect in that it inhibits the shift of 
MBS out of the pellet after treatment with LPA or CA (Fig. 7D). In control experiments, we 
monitored the solubility of cortactin, an F-actin-binding protein that does not interact with 
MBS. As shown in Fig. 7 (C, D), cortactin moves to the insoluble fraction (in response to 
LPA or CA) in a manner independent of p116Rip expression levels. Note that, in growing 
cells, p116Rip is equally distributed between the insoluble and soluble fractions (Mulder et al., 
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2003), whereas in serum-starved cells, p116Rip is found more in the soluble fraction. While 
no shift in p116Rip was detected upon LPA or CA treatment (Fig. 7D, right panel), there is a 
clear correlation between the amounts of p116Rip and MBS in the insoluble fraction. It thus 
appears that the association of MBS with the cytoskeleton depends on p116Rip, in keeping 





Dynamic remodeling of the actomyosin-based cytoskeleton via Rho GTPases is fundamental 
to neurite retraction and outgrowth, axon guidance and dendritic branching ((Luo, 2000; Luo, 
2002). Mutations in components of Rho GTPase signalling pathways have been 
documented in human neurological disorders (for references see (Luo, 2000)), which 
underscores the importance of Rho signalling in the development and function of the 
nervous system. While many details of Rho GTPases and their regulation have been 
elucidated in recent years, it remains unclear how the individual components of Rho-
regulated pathways are assembled into functional signalling modules and how the specificity 
of signal transduction is determined, although scaffold proteins are likely to play an important 
role. 
 
p116Rip as a possible scaffold, linking myosin phosphatase to F-actin 
The present study, together with our previous findings (Mulder et al., 2003), suggests that 
p116Rip serves as a scaffold that links the RhoA/ROCK-regulated myosin phosphatase 
complex to the F-actin cytoskeleton. p116Rip was recently characterised as an actin-binding 
protein that through its N-terminal domain bundles F-actin in vitro and dictates the 
localisation of p116Rip to F-actin-rich structures, which are normally under the control of Rho 
GTPases, in both neuronal and non-neuronal cells (Mulder et al., 2003). Although p116Rip 
was initially isolated as a RhoA-interacting protein in a yeast two-hybrid screen (using 
activated V14RhoA as bait; (Gebbink et al., 1997), our subsequent studies indicated that 
p116Rip is unlikely to interact directly with either RhoA-GTP or RhoA-GDP under normal 
physiological conditions ((Gebbink et al., 2001; Mulder et al., 2003); and chapter 3). 
Overexpression studies showed that the N-terminal actin-binding region of p116Rip can 
disrupt F-actin integrity and inhibit RhoA-regulated actomoysin contractility to promote 
neurite outgrowth in neuroblastoma cells and process extension in NIH3T3 cells (Gebbink et 
al., 1997; Mulder et al., 2003). Interestingly, database analysis reveals that p116Rip is 
evolutionary conserved, as there are predicted orthologues in Drosophila and 
Caenorhabditis elegans (termed “outspread” and “F10G8.8” respectively) showing a similar 
domain arrangement. However, the normal function of p116Rip in cytoskeletal regulation in 
general, and neuritogenesis in particular, has remained elusive. 
Here, we find that the C-terminal coiled-coil domain of p116Rip interacts directly with 
the myosin binding subunits of MLC phosphatase, MBS85 and MBS130, with selected 
(iso)leucine residues in the coiled-coil being essential for interaction with the C-terminal 
leucine zipper in MBS. Co-immunoprecipitation experiments show that the MBS130-p116Rip 
interaction occurs endogenously in neuronal cells (Fig. 4). By modulating and targeting the 
catalytic phosphatase subunit (PP1-δ) to the myosin-II light chain, MBS130 regulates 
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contractile processes such as neurite retraction and/or outgrowth in response to RhoA-
ROCK activation. The closely related MBS85 isoform, which is highly expressed in brain and 
heart (but not in smooth muscle), likely acts in a very similar manner (Tan et al., 2001). In 
vivo studies on MBS85 are hampered, however, by the fact that its endogenous levels in 
cultured cells are much lower than those of MBS130 and antibodies are not yet available 
(Tan et al., 2001).  
In addition to binding to p116Rip, the C-terminal leucine zipper of MBS also interacts 
directly with the GTP-bound, active form of RhoA (Kimura et al., 1996). Binding of MBS130 
to both p116Rip and RhoA-GTP implies the existence of a p116Rip/MBS/RhoA-GTP complex 
in vivo. That the interaction between p116Rip and RhoA-GTP is indirect, and likely very 
transient in nature, may explain why the p116Rip-RhoA association escapes detection under 
physiological conditions. Aside from binding to p116Rip and RhoA-GTP, the leucine zipper of 
MBS has also been reported to bind to a 20-kDa subunit of unknown function (Hartshorne, 
1998), to the ROCK-substrate moesin (at least in epithelial cells; (Fukata et al., 1998) and to 
cGMP-dependent protein kinase, which mediates physiologic relaxation of vascular smooth 
muscle (Surks et al., 1999). This suggests that, depending on cell type or/and its subcellular 
localisation, MBS may exist in distinct signalling complexes with different cellular functions. 
In this respect it should be noted that ROCK and the myosin phosphatase complex can 
regulate the phosphorylation state of proteins other than MLC (Bauman and Scott, 2002). 
Examples include the actin-binding proteins adducin and moesin, which interact directly with 
MBS and are subject to dual regulation by ROCK and MBS (Fukata et al., 1998; Fukata et 
al., 1999; Nakamura et al., 2000). It is therefore conceivable that p116Rip may also be a 
target of myosin phosphatase. Consistent with this possibility, we find that p116Rip is a 
phosphoprotein (J. Mulder, unpublished results) and associates in vivo with the whole 
myosin phosphatase complex, consisting of MBS and the catalytic PP1δ subunit (Fig. 4B). 
How the phosphorylation of p116Rip is regulated and may influence its function remains a 
challenge for future studies. 
 
p116Rip is essential for RhoA/ROCK-regulated neuritogenesis 
Knockdown studies using RNAi in Neuro-2A cells indicate that p116Rip is essential for neurite 
outgrowth induced by extrinsic cues that inhibit RhoA/ROCK activity, notably (i) the RhoA-
inactivating C3 exo-enzyme; (ii) the ROCK inhibitor Y-27632; (iii) removal of serum (a rich 
source of the RhoA-activating agonist LPA); and (iii) treatment of the cells with db-cAMP, 
which raises intracellular cAMP levels to activate protein kinase A and thereby inhibits RhoA-
mediated contractility at multiple levels leading to neurite outgrowth (Dong et al., 1998; 
Essler et al., 2000; Neumann et al., 2002; Snider et al., 2002) and references therein). It is of 
note, however, that p116Rip knockdown does not interfere with MLC phosphorylation induced 
by either LPA or the phosphatase-I inhibitor calyculin A (at least in NIH3T3 cells), nor does it 
inhibit Y27632-induced MLC dephosphorylation (i.e. ROCK regulation of MLC phosphatase 
activity). In other words, it appears that p116Rip loss-of-function prevents ROCK from 
remodeling the F-actin cytoskeleton, but not from regulating MLC (de)phosphorylation. 
Although MLC is dephosphorylated (by Y27632 treatment), p116Rip-deficient cells maintain 
their “contracted” morphology. MLC-independent regulation of contractility is not without 
precedent, however (Seasholtz, 2003). Taken together with our previous data, the present 
results suggest a model in which p116Rip acts as a scaffold to link the RhoA/ROCK-regulated 




Figure 8. Model of p116Rip in association with the ROCK-regulated myosin phosphatase complex 
and F-actin 
We propose that p116Rip acts as a scaffold whose C-terminal coiled-coil binds to the MBS 
subunits (MBS85 and MBS130) of nonmuscle myosin-II phosphatase, while its N-terminal 
domain binds to (and bundles) F-actin (Mulder et al., 2003). MBS is a direct target of ROCK and 
can also bind RhoA, as indicated. The location(s) of the myosin-II-binding sites on MBS is 
somewhat controversial, as binding of myosin-II (or its light-chain) to both N- and C-terminal 
regions has been reported (Hartshorne, 1998; Velasco et al., 2002). MBS phosphorylation 
inhibits PP-I activity and thereby promotes MLC phosphorylation (by one or more candidate 
kinases, including MLC kinase and ROCK) leading to increased myosin-II activity (the 
conventional IIA isoform; (Wylie and Chantler, 2003) and neurite retraction. Dephosphorylation of 
the light chain of myosin IIA may allow myosin IIB action to predominate, leading to enhanced 
growth cone motility and neurite outgrowth (Bridgman et al., 2001; Wylie and Chantler, 2003). 
ANK, ankyrin repeats; LZ, leucine zipper; MIIA, myosin IIA; RLC, regulatory light chain. 
 
As such, p116Rip is essential for actomyosin “relaxation”, which is thought to be initiated by 
the reduced activity of the conventional myosin IIA isoform (Bridgman et al., 2001; Wylie and 
Chantler, 2003). Reduced myosin IIA activity may allow myosin IIB action to predominate, 
leading to enhanced growth cone motility and neurite outgrowth (Bridgman et al., 2001; 
Wylie and Chantler, 2003), as illustrated Fig. 8. 
In a recent study, the human homologue of p116Rip was identified in a yeast-two 
hybrid screen using the C-terminus of MBS130 as bait (Surks et al., 2003). Similar to the 
present findings in neuronal cells, p116Rip and MBS130 were shown to interact in vascular 
smooth muscle cells, which led the authors to hypothesise that p116Rip serves to target 
RhoA to myosin phosphatase to regulate myosin phosphorylation. In this model, p116Rip 
would be essential for RhoA/ROCK-regulated myosin phosphorylation. Our knockdown 
studies show, however, that such is not the case as RNAi-induced loss of p116Rip inhibits 
RhoA/ROCK actomyosin activity but not the MLC (de)phophorylation machinery.
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The identification of other components of the p116Rip complex should provide further 
insight into how it participates in Rho/ROCK regulation of cytoskeletal contractility in general, 
and neuritogenesis in particular. Furthermore, given the importance of the RhoA-actin 
pathway in transcriptional regulation (Hill et al., 1995; Etienne-Manneville and Hall, 2002; 
Miralles et al., 2003), future studies should also examine the role of p116Rip in RhoA 
signalling to the nucleus. 
 
 
Materials and Methods 
 
Cell culture, transfection and materials 
All cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 8% fetal calf 
serum. Human embryonic kidney (HEK)293 cells were transfected using calcium phosphate 
precipitation. N1E-115 and Neuro-2A cells were transfected using FuGENE 6 reagent (Roche 
Diagnostics, Mannheim, Germany) according to the manufacturer’s protocol. COS-7 cells were 
transfected using DEAE–dextran as described previously (Zondag et al., 1996). The following 
materials were obtained from the designated sources: dibutyryl-cAMP (db-cAMP) (Sigma-Aldrich, St. 
Louis, MO), calyculin A (CA) and Y-27632 (Calbiochem, San Diego, CA), 1-oleoyl-LPA (Sigma-
Aldrich), FLAG M2 mouse monoclonal antibody (mAb) (Sigma-Aldrich), rabbit anti-PP1δ and anti-
cortactin 4F11 (Upstate Biotechnology, Lake Placid, NY), anti-actin mAb (Chemicon International, 
Temecula, CA), rabbit anti-green fluorescent protein (GFP) (van Ham et al., 1997), anti-phospho-
MLC-Thr18/Ser19 (Cell Signaling Technology, Beverly, MA), anti-myc 9E10 mAb and anti-HA 12CA5 
mAb from hybridoma supernatants (American Type Culture Collection, Manassas, VA), anti-MBS130 
(CRP, Berkely, CA). Rabbit p116Rip antibodies directed against GST-RBD (amino acids 545-823) 
have been described before (Gebbink et al., 1997). Rabbit anti-p116Rip serum (p116RipNT) directed 
against the N-terminus of p116Rip (amino acids 1-382) was made by immunising rabbits with purified 
GST-NT protein (Mulder et al., 2003). p116RipNT antibodies were used to immunoprecipitate p116Rip 
from N1E-115 lysates because p116Rip antibodies directed against RBD compete with MBS for the 
same binding site on p116Rip. 
 
RNAi and plasmids 
The p116Rip RNAi targeting vectors (pS-GFPp116Rip) were based on a 19-mer sequence present in 
the coding sequence of human, rat and mouse p116Rip: 5’-gagcaagtgtcagaactgc-3’. 64-mer synthetic 
oligonucleotides for cloning into pSuperGFP (pS-GFP) were synthesised, annealed and ligated into 
the pS-GFP plasmid or into the pS plasmid as described (Brummelkamp et al., 2002a). To obtain 
retroviral pSuper constructs (pRS), pS-p116Rip was digested with EcoRI-XhoI and the insert 
containing the RNAi targeting sequence and promotor was ligated into pRS (Brummelkamp et al., 
2002b). The pS-GFP plasmid consists of the pS plasmid including the GFP protein under control of a 
pGK promoter. Adenoviral pAS constructs were designed as follows: pS-p116Rip or pS were digested 
with XhoI-BamHI and the insert containing the RNAi targeting sequence and promotor was ligated 
into pENTR1A of the virapower adenoviral expression system (Invitrogen, Carlsbad, CA). The p116Rip 
point mutants (L857P, L905P, and I919P) were obtained using the QuikChange Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA) using pcDNA3-HA-FLp116Rip (Mulder et al., 2003) as a 
template. pcDNA3-HA-∆Np116Rip was generated from Mb2a-p116Rip-∆N; pcDNA3-HA-NTp116Rip, 
pcDNA3-HA-CTp116Rip and pcDNA3-HA-RBDp116Rip have been described elsewhere (Gebbink et al., 
1997); pcDNA3-HA-FLp190RhoGEF and pcDNA3-HA-Coil-p190RhoGEF are described by (van 
Horck et al., 2001). pXJ40-FLAG-p85 (MBS) and pEFBOS-myc-MBS130 plasmids were kindly 
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provided by Dr. T. Leung (Institute of Molecular and Cell biology, Singapore) and Dr. K. Kaibuchi 
(Nagoya University, Nagoya, Japan), respectively. 
 
Yeast two-hybrid analysis 
Mb2a-p116Rip-∆N, in which p116Rip lacking the N-terminus is fused to the GAL4 DNA-binding domain 
of Mb2a, was generated by polymerase chain reaction (PCR) using primers 5’-
acgcgtcgacccggtaccactccacagaatcctccatga-3’ (forward) and 5’-
ataagaatgcggccgcaagctttcagttatcccatgagacctg-3’ (reverse). The PCR product was digested with SalI-
NotI and ligated into Mb2a. Mb2a-p116Rip-∆N was integrated into the genome of yeast strain Y190 
and used as bait in screening a human testis cDNA library in pVP16, according to earlier described 
procedures (Gebbink et al., 1997). Binding specificity of cDNAs obtained from positive yeast colonies 
was confirmed by retransformation assays. 
 
Western blotting and immunoprecipitation 
COS-7 cells co-expressing various constructs were scraped in ice-cold lysis buffer (1% NP-40, 50 mM 
Tris pH 7.4, 200 mM NaCl, 2.5 mM MgCl2, 10% glycerol, supplemented with protease inhibitors). 
Extracts were clarified by centrifugation and precleared with 0.5% bovine serum albumin (BSA)-
blocked protein-A–Sepharose beads for 1 hour at 4 °C. Precleared lysates were incubated overnight 
with anti-hemagglutinin (HA) at 4 °C and immunocomplexes were removed by incubation with protein-
A-Sepharose beads for 30 min at 4 °C. Beads were washed, resuspended in Laemmli sample buffer 
and boiled. Samples were separated by SDS–PAGE and analysed by western blotting using anti-myc, 
anti-HA, or anti- FLAG antibodies. N1E-115 lysates were prepared similarly and supernatants were 
precleared with 0.5% BSA-blocked protein-A-Sepharose beads pre-coupled to either pre-immune 
rabbit serum (IgG), p116RipAB, PP1δ, or anti-MBS antibodies overnight at 4 °C. Beads were washed, 
resuspended in Laemmli sample buffer and boiled. Samples were separated by SDS–PAGE and 
analysed by western blotting using anti-MBS, anti-p116Rip, or anti-PP1δ antibodies. HEK293 cells 
were co-transfected (1:1) with plasmids as indicated; 96 hrs after transfection, cells were lysed as 
before. Blots were incubated with anti-HA and/or anti-actin mAbs. Neuro2A cells were transfected 
with plasmids and lysed similarly 96 hrs after transfection. Blots were incubated with rabbit anti-
p116Rip, rabbit anti-GFP and anti-actin mAb. In all cases, Bradford protein assays were performed on 
the lysates to test for equal loading on SDS-PAGE. 
 
Fluorescence microscopy 
In RNAi studies, Neuro-2A cells were transfected with pS-GFP, pS-GFPp116Rip or a combination of 
pS-GFP/pS-GFPp116Rip and pcDNA3-HA-FLp116Rip variants (ratio 1:8). To induce neurite outgrowth, 
N1E-115 and Neuro-2A cells were either exposed for 48 hrs to serum-free Neurobasal medium 
supplemented with B-27 (NB-B27, Invitrogen) containing db-cAMP (1 mM); alternatively, cells were 
incubated with Y-27632 (10 µM) for 8 hrs. Fluorescence and corresponding phase-contrast images 
pictures were taken on a Zeiss Axiovert microscope equipped with a CCD camera. GFP-positive cells 
were analysed for neurite outgrowth, defined as processes longer than one cell body diameter. 
 
Retroviral infections and detection of myosin light chain phosphorylation 
Phoenix-Eco package cells were transfected with pRS or pRS-p116Rip. The supernatant containing 
viral particles was harvested at 48 hrs and 72 hrs after transfection. For infection of NIH3T3 cells, cells 
were incubated with 1 ml of viral stock in the presence of 10 µl Dotap (1 mg/ml; Roche Diagnostics). 
The following day cells were washed with phosphate-buffered saline (PBS) and fresh medium was 
added. 72 hrs after infection, NIH3T3 cells were serum starved (0.1% fetal calf serum (FCS)) for 24 
hrs or left in serum-containing media and then stimulated for 10 min with 2.5 µM LPA, 5 min with 0.1 
µM calyculin A (CA), or 45 min with 10 µM Y-27632. Cells were washed once with ice-cold PBS and 
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lysed in Laemmli’s sample buffer. Cell lysates were subjected to immunoblotting using anti-phospho-
MLC-Thr18/Ser19, rabbit p116Rip antibodies and anti-actin mAb. 
 
Adenoviral infections and solubility assay 
Adenovirus was produced according to the manufacturer’s protocol (virapower adenoviral expression 
system; Invitrogen). N1E-115 cells were infected with either pAS control or pAS-p116Rip virus (by 
using equal amounts of virus particles per cell). At 72 hrs after infection, cells were serum starved. 
The following day cells were stimulated for 5 min with 2.5 µM LPA, or 4 min with 0.1 µM calyculin A 
(CA). The Triton solubility assay was performed as described (Mulder et al., 2003). In brief, detergent 
lysates were centrifuged for 30 min using an Eppendorf table centrifuge. Equal amounts of pellet and 
supernatant fractions were subjected to SDS-PAGE. Proteins were detected by immunoblotting using 
antibodies against MBS, cortactin, actin and p116Rip. 
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p116Rip inhibits RhoA-mediated SRF activation 
 
 








The small GTPase RhoA regulates diverse cellular processes including cytoskeletal 
reorganisation and transcriptional activation. p116Rip is an F-actin-bundling protein that binds 
to the regulatory myosin-binding subunit (MBS) of myosin-II phosphatase. Overexpression 
and knockdown studies suggest that p116Rip interferes with Rho-mediated cytoskeletal 
contraction. Here we find that p116Rip inhibits RhoA-induced activation of the transcription 
factor SRF without affecting the activation state of RhoA. In addition, we show that p116Rip 
undergoes oligmerisation through its C-terminal coiled-coil domain. Abolition of p116Rip’s 
ability to oligomerise or bind MBS did not affect p116Rip inhibition of RhoA-induced 
transcription. These results, together with our previous findings, show that p116Rip influences 
RhoA signalling at a point downstream of RhoA and Rho-kinase. We propose that p116Rip 
interferes with RhoA-mediated transcription through its ability to disassemble the F-actin 





Rho GTPases are involved in a wide range of cellular responses, ranging from changes in 
cell morphology to transcriptional activation and cell cycle progression (Malliri and Collard, 
2003; Raftopoulou and Hall, 2004; Coleman et al., 2004; Burridge and Wennerberg, 2004). 
For example, activation of RhoA (by LPA or serum) leads not only to cytoskeletal contraction 
in diverse cell types (Ridley and Hall, 1992; Jalink et al., 1994), but also to activation of the 
SRE response element via activation of the transcription factor SRF (Hill et al., 1995). 
Changes in actin dynamics are both necessary and sufficient for SRF activation 
(Sotiropoulos et al., 1999; Posern et al., 2002). Like all GTPases, RhoA signals via 
downstream effectors that are activated upon binding to active, GTP-bound RhoA 
(Aspenstrom, 1999; Bishop and Hall, 2000; Ridley, 2001). SRF activation is mediated by two 
distinct RhoA effectors, ROCK and mDia, which act cooperatively to induce F-actin 
assembly and stabilisation (Copeland and Treisman, 2002; Geneste et al., 2002). Recently, 
the MAL protein was found to be a cellular sensor for the amount of G-actin. Upon depletion 
of the G-actin pool, MAL distributes to the nucleus where it mediates SRF activation 
(Miralles et al., 2003). RhoA-induced actomyosin contractility is driven by the action of the 
same downstream effectors, mDia and ROCK (Nakano et al., 1999; Watanabe et al., 1999). 
Next to stabilising F-actin, ROCK activation leads to inhibition of myosin light chain (MLC) 
phosphatase by phosphorylating the regulatory myosin-binding subunit (MBS), leading to 
enhanced MLC phosphorylation and actomyosin contractility (Kimura et al., 1996; Kawano et 
al., 1999). 
Using a yeast two-hybrid screen to search for RhoA effectors we have previously 
identified a ubiquitously expressed protein of 116 kDa, named p116Rip, that interacted with 
constitutively active RhoA (Gebbink et al., 1997). Subsequent studies revealed that p116Rip 
is an F-actin binding protein with F-actin bundling properties in vitro. RNAi-induced 
knockdown of p116Rip inhibits cell spreading and neurite outgrowth in response to signals 
that lead to inhibition of the RhoA pathway (Mulder et al., 2004). In addition, overexpression 
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of p116Rip (or its N-terminal actin-binding domain) disrupts the actin cytoskeleton and thereby 
inhibits actomyosin contractility (Gebbink et al., 1997; Mulder et al., 2003). Furthermore, we 
and others reported that p116Rip interacts with the regulatory myosin-binding subunit (MBS) 
of myosin II phosphatase (Surks et al., 2003; Mulder et al., 2004; Koga and Ikebe, 2005) and 
p116Rip may target MBS to the actin cytoskeleton (Mulder et al., 2004). Thus, p116Rip may 
interfere with RhoA signaling at multiple levels. 
The p116Rip sequence contains two proline-streches, two PH domains, and a C-
terminal coiled-coil structure, which interacts with the leucine zipper of MBS (Surks et al., 
2003; Mulder et al., 2004). Here, we show that the coiled-coil domain of p116Rip, consisting 
of 6 coiled-coils, is both necessary and sufficient to mediate homo-oligomerisation of p116Rip. 
Point mutations within the coiled-coil domain block the ability of p116Rip to bind MBS or to 
oligomerise. Furthermore, we find that overexpression of p116Rip inhibits RhoA-mediated 
SRF activation without affecting active RhoA levels. Mutational analysis reveals that this 
inhibition does not depend on p116Rip-MBS interaction or on oligomerisation, but correlates 
with p116Rip’s ability to disrupt the cytoskeleton. We conclude that p116Rip acts downstream 
in the RhoA-ROCK pathway and may abrogate RhoA-induced SRF activation through its 
ability to interact with and disassemble the F-actin cytoskeleton. 
 
 
Figure 1. The coiled-coil 
domain of p116Rip
The coiled-coil probabilities of 
p116Rip (aa 600-1024) were 
detected by MULTICOIL (Wolf 
et al., 1997) using default 
settings; a probability cutoff of 
0.5 and a window of 28 
residues. Blue and red lines 
mark the location of the six 
predicted dimeric or trimeric 
coiled-coils, respectively. The 
sum of the two probabilities 
represents the propensity for the 
region forming any sort of coiled 
coil (black line). 
 
 
Results and Discussion 
 
The coiled-coil of p116Rip mediates homo-oligomerisation 
Aside from two PH domains, p116Rip contains a coiled-coil structure, as predicted by the 
MULTICOIL program (Wolf et al., 1997). Coiled-coils consist of α-helices wrapping around 
each other forming a supercoil. The sequences of coiled-coils consist of a heptad repeat 
pattern, (abcdefg)n, in which residues at the a and d positions are often hydrophobic, and 
residues at the e and g positions are predominantly charged (Burkhard et al., 2001; Mason 
and Arndt, 2004). As shown in Fig. 1, the C-terminus of p116Rip (aa 600-1024) contains six 
coiled-coil regions with probabilities >0.5 or 1. For comparison, the extended coiled-coil 
domain of myosin heavy-chain, to which the coiled-coil of p116Rip is similar, has a probability 
of 1. Furthermore, the MULTICOIL program predicted that coiled-coil regions 1 to 4 and 6 




Coiled-coil structures often mediate homo- or hetero-oligomerisation (Burkhard et al., 
2001; Mason and Arndt, 2004; Marianayagam et al., 2004). To investigate whether p116Rip 
oligomerises through its coiled-coil domain, we generated HA-tagged truncation mutants of 
the C-terminal part of p116Rip and expressed them in COS-7 cells. Indeed, p116Rip was 
found to oligomerise since full-length Myc-p116Rip precipitated with full-length HA-p116Rip 
(Fig. 2A, lanes 1-3). Furthermore, all p116Rip truncation mutants containing the coiled-coil 
domain precipitated Myc-tagged p116Rip from COS-7 cell lysates (Fig. 2A). No 
oligomerisation was detected with a truncated coiled-coil mutant (‘RBD’; aa 545-823) or with 
the isolated actin-binding domain of p116Rip (‘NT’; aa 1-382) (Fig. 2A), indicating that the 
coiled-coil domain of p116Rip mediates oligomerisation in vitro. To test the importance of the 
coiled-coil domain for oligomerisation, we made GST fusion proteins of p116Rip lacking either 
the actin-binding domain or the coiled-coil domain, ∆Np116Rip-GST (aa; 376-1024) and 
∆Cp116Rip-GST (aa; 1-713), respectively (Fig. 2B). The ∆Cp116Rip-GST mutant, lacking most 
of the coiled-coil (713-1024) failed to precipitate myc-p116Rip when co-expressed in COS-7 
cells. Thus, the coiled-coil region of p116Rip (aa 671-976) is necessary for oligomerisation of 
p116Rip (Fig. 2C). 
Coiled-coil proteins can be grouped into two classes. The first class is defined by 
long coiled-coil domains of several hundred amino acids. The second class is comprised of 
short coiled-coil domains of six or seven heptad repeats, also called leucine zippers. As 
coiled-coil sequences generally interact with other coiled-coil sequences, both classes are 
frequently found as homo- and hetero-dimerisation domains (Burkhard et al., 2001; 
Figure 2. The coiled-
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 82Figure 2-continued (c) Schematic representation of the oligomerisation via the coiled-coil
domain of p116Rip as determined in COS-7 cells; + denotes p116Rip oligomerisation or MBS
binding (Mulder et al., 2004). -, empty vector; wt, wild-type p116Rip; NT, N-terminal actin-
binding region domain (Mulder et al., 2003); CT, C-terminal region; RBD, 'Rho-binding'
domain (Gebbink et al., 1997); ∆N, p116Rip lacking the N-terminal region; ∆C, p116Rip
lacking the C-terminal region; ND, not done.rianayagam et al., 2004). Replacement of (iso)leucine residues at position a or d with 
nine, valine or proline affects the stability of the coiled-coil structure and often abolishes 
led-coil based binding (Wagschal et al., 1999; Tripet et al., 2000). 
Part of the coiled-coil domain of p116Rip (aa 823-1024) (Fig. 2C) was recently shown 
etero-oligomerise with the leucine zipper of MBS (Surks et al., 2003; Mulder et al., 2004). 
addition, substitution of residues Leu(857) and Ile(919) in p116Rip with Pro residues 
wed that these residues were critical for the direct interaction with the leucine-zipper 
ain of MBS. Next, we asked which leucine-isoleucine motifs in the coiled-coil are 
essary for homo-oligomerisation. The L857P, L905P, and I919P point mutants were used 
ether with double mutants L857P/L864P, L905P/I912P and I919P/L926P. All residues are 
ated at the a position of the heptad repeat, except for residues Leu(857) and Leu(864) 
ich are located at the d position (Fig. 3A). Oligomerisation was examined by co-
cipitation of Myc-p116Rip with the HA-tagged p116Rip mutants. As shown in Fig. 3B, only 
ble mutants L905P/I912P and I919P/L926P failed to oligomerise. We conclude that 
idues Ile(912) and Leu(926) in the 5th coil of p116Rip are critical for p116Rip homo-
omerisation. 
To study a possible overlap of p116Rip and MBS binding regions within the coiled-coil 
116Rip (Fig. 2C), the double mutants were also tested for association with MBS130 and 
 MBS85. All double mutants failed to interact with either MBS85 or MBS130 (Fig. 4). This 
icates that, in addition to residues Leu(857) and Ile(919), residue Ile(912) is critical for a 
ct interaction with the leucine-zipper domains of MBS85 and MBS130. These data are 
marised in Table 1. In conclusion, p116Rip-p116Rip and p116Rip-MBS oligomerisation is 
diated by an overlapping region within the coiled-coil domain of p116Rip. Furthermore, the 
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Figure 3. (Iso)leucine 
residues in the coiled-coil 
of p116Rip mediate homo-
oligomerisation 
(a) Representation of 
residues 851-1024 of the 
coiled-coil domain of 
p116Rip. Coil regions and 
hydrophobic residues at 
the a and d positions are 
indicated. (Iso)leucines in 
bold were mutated to 
proline by site-directed 
mutagenesis. (b) COS-7 
cells were co-transfected 
with plasmids encoding 
either Myc-p116Ripwt and 
indicated HA-tagged 
(iso)leucine mutants of 
p116Rip or an empty HA-
tagged plasmid as control 
(-). Total cell lysates (TL) 
analysed for p116Rip expression are shown (upper panels). Immunoprecipitation (IP) of HA-tagged 
p116Rip and co-precipitation of wild-type myc-p116Rip was analysed by immunoblotting (IB) using α-HA 
and α-Myc. Note that the double mutant L905P/I912P has a higher mobility, indicating distortion of the 
coiled-coil structure (see also Fig. 4). 
 
Figure 4. (Iso)leucine 
residues in the coiled-
coil of p116Rip mediate 
binding to MBS85 and 
MBS130. 
COS-7 cells were co-
transfected with 
plasmids encoding 





mutants or an empty 
HA-tagged plasmid as 
control (-). Total cell 
lysates (TL) analysed for 
MBS85 and MBS130 
expression are shown 
(first and fourth panels). 
unoprecipitation (IP) 
of HA-tagged proteins 
and co-precipitation of 
MBS85 or MBS130 was 
analysed by 
immunoblotting (IB) 
using α-HA, α-FLAG, 




ingle and double (iso)leucine mutants of p116Rip can serve as a tool to study the importance s



























MBS p116Ripp116Rip mutants 
Table 1. Summary of results 
Interaction with p116Rip in COS-7 cells 
+++ = strong interaction 
-/+ = weak interaction 
- = no interaction 
 
p116Rip interferes with RhoA-induced activation of SRF 
onse factor (SRF) (Hill et al., 1995) RhoA, Rac1, and Cdc42 can activate the serum resp
through their ability to induce actin polymerisation. It was recently shown that MAL, a G-
actin-associated SRF coactivator, translocates from the cytoplasm to the nucleus in 
response to Rho-induced actin polymerisation (Miralles et al., 2003). Since overexpression 
of p116Rip interferes with RhoA-induced cytoskeletal changes (Gebbink et al., 1997; Mulder 
et al., 2003), we examined how p116Rip may affect RhoA-mediated SRF activation. We used 
a reporter assay in which the luciferase gene is under the control of a c-Fos serum-
responsive promotor element (pSRE.L). Since this modified SRE element depends on SRF, 
it specifically reports Rho GTPase signalling (Mao et al., 1998). HEK293 cells were co-
transfected with pSRE.L, RhoV14 or p190RhoGEF (van Horck et al., 2001) and full-length 
p116Rip. As shown in Fig. 5 (A, B), expression of p116Rip inhibits RhoV14- or p190RhoGEF-




Figure 5. p116Rip expression 
interferes with RhoA-mediated 
SRF activation 
(a, b) HEK293 cells were 
transfected with the SRE.L-
luciferase plasmid, a β-
galactosidase control plasmid 
and indicated amounts of 
either HA-p190RhoGEF (a), 
or myc-RhoV14 (b), and HA-
p116Rip. As negative controls, 
empty vector was transfected 
into cells (-) or cells were 
transfected with SRE.L, and 
β-galactosidase plasmids, and 
empty vectors (C). Lower 
panels show the expression of 
transfected proteins in the 
total cell lysates. (c) p116Rip 
overexpression does not 
interfere with RhoA activity. 
COS-7 cells were transfected 
with empty vector (-), HA- c
p190RhoGEF-DH/PH, or 
p116Rip-myc. Cells were 
serum-starved overnight, 
stimulated with 1 µM LPA for 
3 min, and lysed 48 h after 
transfection. Samples were 
analysed for levels of 
activated RhoA (GTP-RhoA) 
by immunoblotting (IB) using 
α-RhoA. TL were analysed for 
α-RhoA, α-myc, and α-HA. 
Lines indicate duplicate 
samples. (d) HEK293 cells 
were transiently transfected 
as in b with or without 0.5 µg 
myc-RhoV14 and increasing 
amounts of HA-p116Ripwt/HA-
p116Rip mutants (0.5, 1.0, and 





p116Rip does not affect RhoA activation 
Overexpression of p116Rip induces a dn-RhoA phenotype (Gebbink et al., 1997; Mulder et 
al., 2003) and inhibits RhoA-dependent SRF activation (Fig. 5A, B). Therefore, we 
investigated whether p116Rip affected RhoA signalling at the level of RhoA activation. p116Rip 
was overexpressed in COS-7 cells and RhoA activation was analysed before and after LPA 
stimulation. As a positive control COS-7 cells were transfected with an activated mutant of 
p190RhoGEF (DH/PH) (van Horck et al., 2001). Basal Rho-GTP levels were unaffected by 
overexpression of p116Rip (Fig. 5C, upper panel, compare lanes 1 and 5-6). LPA activates 
RhoA in both control and p116Rip transfected cells (Fig. 5C, upper panel, compare lanes 1 to 
3-4, and lanes 5-6, to 7-8). Thus, p116Rip does not interfere with LPA-induced RhoA 
activation. 
 
Inhibition of SRF activity by p116Rip does not depend on its oligomerisation or interaction with 
MBS 
We next examined whether inhibition of SRF activity depends on p116Rip’s ability to homo-
oligomerise or associate with MBS. Wild-type p116Rip, (iso)leucine single mutants that no 
longer bind MBS, or (iso)leucine double mutants that fail to interact with both MBS and 
p116Rip, were co-expressed with activated RhoA in HEK293 cells and SRF activation was 
determined. A deletion mutant of p116Rip containing only the second PH domain was used 
as a negative control. Wild-type p116Rip and (iso)leucine mutants are all equally able to 
inhibit the RhoA-induced SRF activation (Fig. 5D), indicating that the ability of p116Rip to 
homo-oligomerise or interact with MBS does not contribute to its affect on SRF activity 
(Table 2). 
 
Inhibition of SRF activity by p116Rip correlates with its capacity to disrupt the cytoskeleton 
p116Rip might modulate Rho-induced SRF activation through its effect on F-actin containing 
structures. To investigate this, we studied the cytoskeletal organisation of NIH3T3 cells 
expressing the (iso)leucine mutants of p116Rip. Expression of all mutants results in a 
dramatic loss of stress fibres similar to wild-type p116Rip (Fig. 6). Less than 15% of the 
p116Rip wild-type or (iso)leucine transfected NIH3T3 cells contain stress fibres, compared to 
>60% of GFP-expressing control cells. Thus, the effect of p116Rip overexpression on SRF 






Figure 6. Expression p116Rip (iso)leucine mutants induces a loss of stress fibres in NIH3T3
cells 
NIH3T3 cells were transfected with HA-tagged p116Rip wild-type (wt), HA-tagged p116Rip
(iso)leucine mutants, GFP, or p116Rip-GFP fusion constructs. Transfected cells were
analysed for the presence of stress fibres as previously described (Mulder et al., 2003). 











RhoV14 + p116Rip wt
RhoV14 + p116Rip L857P 
RhoV14 + p116Rip I919P 
RhoV14 + p116Rip L905P/I912P 




























Loss of stress 
fibres c 
a Interaction with p116Rip in COS-7 cells: 
  +++ = strong interaction 
  -/+ = weak interaction 
  - = no interaction 
b SRF activity induced by RhoV14 in the absence or presence of 1.5 µg p116Rip wt or 
p116Rip mutants 
c As determined in NIH3T3 cells upon overexpression of p116Rip wt or p116Rip 





We have shown that p116Rip, through its C-terminal coiled-coil domain, homo-oligomerises 
and hetero-oligomerises with MBS. Moreover, the (iso)leucine mutants described here will 
allow to address the importance of the MBS-p116Rip and p116Rip-p116Rip complexes. Future 
studies should investigate whether homo-oligmerisation occurs in vivo and how homo-
oligomerisation contributes to the function of p116Rip. 
The present data show that p116Rip expression abrogates RhoA signaling to the 
nucleus. This is in line with earlier observations showing that p116Rip expression levels are 
correlated inversely with an active RhoA phenotype (Mulder et al., 2003; Mulder et al., 
2004). Interestingly, p116Rip was found to localise to the nucleus, although the function of 
this localisation remains unknown. However, our data exclude the possibility that the MBS-
p116Rip interaction or p116Rip oligomerisation plays a role in the transcriptional inhibition by 
p116Rip. Indeed, MBS is not directly involved in actin polymerisation but is primarily involved 
in the regulation of MLC phosphorylation downstream of ROCK. In addition, a role of MBS in 
SRF activation has not been reported. It has been suggested that p116Rip may inhibit RhoA 
activity directly, acting as a GTPase-activating protein (GAP) (Koga and Ikebe, 2005). This 
seems quite unlikely, as p116Rip overexpression does not affect active RhoA levels and 
p116Rip does not contain a typical GAP domain. Furthermore, RhoA inactivation through an 
alleged GAP activity of p116Rip can be excluded in our SRF-reporter assays, since we use 
constitutively active RhoA that cannot undergo GTP hydrolysis. 
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p116Rip inhibition of RhoA signalling 
We have shown that p116Rip overexpression antagonises RhoA signalling, as evidenced by 
loss of stress fibres, induction of neurite outgrowth and inhibition of gene transcription (Fig. 5 
and 6) (Gebbink et al., 1997; Mulder et al., 2003; Mulder et al., 2004), but it has been 
unclear at what level p116Rip interferes with RhoA signalling. Collectively, our studies show 
that p116Rip acts downstream of the RhoA-ROCK pathway, because: (1) p116Rip 
overexpression does not affect basal levels of activated RhoA or activation of RhoA by LPA 
(Fig. 5C); (2), knock-down of p116Rip prevents neurite outgrowth induced by the ROCK 
inhibitor Y-27632 (Mulder et al., 2004); and (3), p116Rip does not bind ROCK ((Koga and 
Ikebe, 2005) and our unpublished data). 
 
 
Figure 7. Model of p116Rip counteracting the RhoA pathway. RhoA activation leads to 
reorganisation of the actin cytoskeleton through the activation of the RhoA effector proteins 
ROCK and mDia. Activation of these effectors leads to the stabilisation of actin filaments, 
accumulation of F-actin, and increased actomyosin contractility. As a consequence, MAL is no 
longer sequestered by G-actin and relocates to the nucleus where it associates with SRF and 
activates SRE-mediated gene expression. We propose that p116Rip interferes with the RhoA 
pathway at multiple levels: 1) by its direct affect on F-actin leading to inhibition of RhoA-mediated 
gene transcription and actomyosin contractility, 2) by acting in parallel with MLCP resulting in 
reduced actomyosin contractility (Mulder et al., 2004)d}4). SRF, serum response factor; SRE, 
serum response element; MAL, megakaryocytic acute leukaemia protein, ROCK, Rho-kinase; 
LIMK, LIM-kinase; MLC, myosin light chain; MLCP, MLC phosphatase. 
 
Activation of the transcription factor SRF is regulated by changes in the G-actin pool 
(Sotiropoulos et al., 1999; Miralles et al., 2003). We have previously shown that p116Rip is an 
F-actin-binding protein that, upon overexpression, leads to disassembly of the actomyosin 
cytoskeleton (Mulder et al., 2003). Here, we show that the inhibition of Rho-induced SRF 
activity by p116Rip correlates with the ability of p116Rip to disrupt the cytoskeleton. Therefore, 
our data suggest a model in which overexpression of p116Rip disassembles the F-actin 
cytoskeleton, leading to an increase in the G-actin pool (downstream of RhoA) and 
decreased SRF activation (Fig. 7). Future studies should address how p116Rip may affect G- 
and F-actin levels. 
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From our RNAi studies, we concluded that p116Rip acts as a scaffold protein that 
targets MBS to the actin cytoskeleton (Mulder et al., 2004). Whilst the RhoA/ROCK pathway 
leads to phosphorylation of MLC, MBS antagonises the RhoA pathway through 
dephoshorylation of MLC and other cytoskeleton-associated proteins (Fukata et al., 1999; 
Nakamura et al., 2000; Amano et al., 2003). In conclusion, p116Rip acts downstream of the 
Rho/ROCK pathway probably in tandem with MBS and F-actin to negatively influence the 
RhoA pathway and thereby induces relaxation of the actomyosin cytoskeleton (Fig. 7). 
 
 
Materials and Methods 
 
Cell culture, transfection and materials 
All cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 8% fetal calf 
serum. COS-7 cells were transfected using DEAE–dextran as described previously (Zondag et al., 
1996). The following materials were obtained from the designated sources: FLAG M2 mouse 
monoclonal antibody (mAb), 1-oleoyl-LPA (Sigma), anti-GST 2F3 mAb, anti-myc 9E10 mAb and anti-
HA 12CA5 mAb from hybridoma supernatants (ATCC); anti-RhoA 26C4 mAb (Santa Cruz 
Biotechnology), 3F10 anti-HA rat mAb (Roche). 
 
Plasmids 
pcDNA3-HA-∆Np116Rip, pcDNA3-HA-FLp116Rip, pMT2sm-FLp116Rip-GST, pcDNA3-HA-NTp116Rip, 
pcDNA3-HA-CTp116Rip and pcDNA3-HA-RBDp116Rip have been described elsewhere (Gebbink et al., 
1997; Mulder et al., 2003; Mulder et al., 2004). pcDNA3-HA-p190RhoGEF is described by (van Horck 
et al., 2001). pcDNA3-FLp116Rip-myc was generated by digestion of pcDNA3-FLp116Rip with NotI-NotI 
and ligation of the insert into pcDNA3-Myc. pMT2sm-HA-p190RhoGEF-DH/PH is described by (van 
Horck et al., 2001). pcDNA3-HA-PHp116Rip (aa 383-488) was generated by PCR using primers 5'-
cctgacctgctgaatttcaag-3' (forward) and 5'-atctggggcagatgctgg-3' (reverse). The PCR product was 
digested with KpNI-EcoRI and ligated into pcDNA3-HA. SRE.L-luciferase plasmids and GST-C21, are 
described elsewhere (Mao et al., 1998; Sander et al., 1999). The construction of dominant-active 
RhoA pMT2sm-myc construct has been described previously (Gebbink et al., 1997). pMT2sm-
∆Np116Rip-GST was constructed by ligation of a BstXI-SalI, blunt-ended fragment out of FLp116Rip-
peGFPN1 into SmaI cut pMT2sm-GST. pMT2sm-∆Cp116Rip-GST was generated by digestion of 
pMT2sm-FLp116Rip-GST with SmaI and ligation the insert into SmaI-NotI, blunt-ended pMT2sm-GST. 
The p116Rip double point mutants (L857P/L864P, L905P/I912P, and I919P/L926P) were made with 
the QuikChange Site-Directed Mutagenesis Kit (Stratagene) using the p116Rip single point mutants 
(L857P, L905P, and I919P, (Mulder et al., 2004)) as a template. pXJ40-FLAG-p85 (MBS) and 
pEFBOS-myc-MBS130 plasmids were kindly provided by Dr. T. Leung and Dr. K. Kaibuchi, 
respectively. 
 
Western blotting, immunoprecipitation, and pull-down assays 
COS-7 cells co-expressing various constructs were scraped in ice-cold lysis buffer A (1% NP-40, 50 
mM Tris pH 7.4, 200 mM NaCl, 2.5 mM MgCl2, 10% glycerol, supplemented with protease inhibitors). 
Extracts were clarified by centrifugation and precleared with 0.5% BSA-blocked protein-A–Sepharose 
beads for 1 hour at 4 °C. Precleared lysates were incubated overnight with anti-HA at 4 °C and 
immunocomplexes were removed by incubation with protein-A-Sepharose beads for 30 min at 4 °C. 
Beads were washed, resuspended in Laemmli sample buffer and boiled. Samples were separated by 
SDS–PAGE and analyzed by western blotting using anti-myc, anti-HA, or anti- FLAG antibodies. 
GST pulldowns were performed as follows. COS-7 cell lysates were prepared as above. 
GSH-sepharose was used to collect the p116Rip-GST protein precipitates. Beads were washed, eluted 
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in Laemmli sample buffer and boiled. Samples were separated by SDS–PAGE and analysed by 
western blotting using myc or GST antibodies. 
 
SRF-mediated luciferase gene transcription 
Hek293 cells were seeded at a density of 1 x 105 cells per well in 12-well plates. Cells were 
transfected with pCMV-β-gal (0.2 ug), pSRE.luc (0.2 µg) and indicated plasmids. The total DNA per 
well was kept constant at 3 µg DNA per well using pcDNA3 and/or pMT2sm empty vectors. 24 h after 
transfection fresh DMEM containing 0.5 % FCS was added to the cells. 48 h after transfection, cells 
were lysed in 200 µl Reporter Lysis Buffer (25 mM Tris-HCl pH 7.8, 2 mM DTT, 2 mM EDTA, 10% 
glycerol and 1% Triton X-100). Luciferase activity was measured using 20 µl of lysate and 50 µl of 
Luciferase Substrate (Promega) at 495 nm. β-Galactosidase measurements were used to normalise 
transfection efficiency. Luciferase and β-Galactosidase activity were quantified using a Victor 
luminometer (Wallac, Turku, Finland). Equal amounts of lysate were subjected to SDS-PAGE and 
western blotting to determine the expression of transfected proteins. The experiments were repeated 
at least three times; representative experiments are shown. 
 
RhoA activation assay 
RhoA activity was analysed as described (van Horck et al., 2001), using a GST-fusion protein 
containing the RhoA binding domain of Rhotekin (GST-C21). In brief, COS-7 cells were transfected 
with indicated constructs, stimulated and lysed in Nonidet P-40 fish buffer. Cleared lysates were 
incubated for 45 min at 4 °C with 20 µg of GST-C21 coupled to GSH-Sepharose. The beads were 




NIH3T3 cells were grown on gelatin-coated glass coverslips in six-well plates. Cells were fixed 48 h 
after transfection in 3.7% formaldehyde in PBS for 10 min, permeabilised (0.1% Triton X-100/PBS; 2 
min), blocked (1% BSA/PBS; 30 min), and incubated for 1 h with primary HA antibody 3F10. 
Subsequently, cells were washed and incubated with secondary antibodies (Goat-anti-rat-fluorescein 
isothiocyanate (Rockland); 30 min) together with rhodamine-conjugated phalloidin (Molecular Probes). 
Coverslips were mounted in Vectashield and analysed using a Leica TCS-NT confocal microscope. 
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Cells sense changes in their environment via specific sensors, so-called receptors that are 
located on the outer surface, at the plasma membrane. Receptors are activated by binding 
of their cognate ligands, signal molecules such as growth factors, which leads to distinct 
cellular responses. Stimulated receptors pass on the message by triggering a wide range of 
signalling cascades involving successive activation of enzymes and generation of “second 
messengers” (signal transduction). Which cellular responses arise after stimulation of a 
receptor depends on the signal molecule (agonist), the type of receptor, and the combination 
of both. In this way, growth factors that bind to their specific receptor encourage cells to 
divide. Similarly, next to affecting cell growth, receptor agonists can promote alterations in 
cellular morphology and motility. Changes in cell morphology and polarity are fundamental 
for many physiological (and pathological) processes, and are brought about by the dynamic 
regulation and reorganisation of the cytoskeleton. 
The cytoskeleton provides the strength and motility of a cell and consists of three 
types of networks: the actin cytoskeleton, the microtubule network and intermediate 
filaments. These networks are characterised by filaments, which arise through the joining of 
single subunits into large strands (polymerisation). A higher order structure of the actin 
cytoskeleton is accomplished by the organisation of actin filaments into networks by actin-
crosslinking and -bundling proteins. Other actin-binding proteins (ABPs) function as scaffolds 
holding the actin network and associating proteins together. In addition, various ABPs 
stimulate or reduce polymerisation of actin, thereby affecting the length and amount of actin 
filaments. So, the organisation of the actin network is determined by the combined activities 
of ABPs.  
The Rho family of small GTPases, in particular the members RhoA, Rac, and Cdc42, 
has a central role in the regulation of the actin cytoskeleton. Rho GTPases act as molecular 
switches that are inactive when complexed with GDP and active when bound to GTP. 
Receptors that induce remodelling of the actin cytoskeleton all converge on these Rho 
GTPases to elicit their effects. Activated Rho GTPases transmit the signal to proteins that 
directly affect the assembly and disassembly of the cytoskeleton, such as ABPs. For 
example, activation of RhoA leads to cell contraction by the actin-associated motor protein 
myosin, which exerts force on actin filaments. 
Besides their effects on actin reorganisation, Rho GTPases are involved in many 
other cellular responses, such as gene transcription leading to changes in protein 
expression. Serum or its major constituent lysophosphatidic acid activate for instance the 
serum response factor (SRF), which controls many growth factor-regulated genes, through 
RhoA-dependent increases in actin polymerisation.  
Deregulation of Rho GTPase activity can contribute to various aspects of 
tumourigenesis. Therefore, studying the Rho GTPase signal transduction pathway will 
increase our understanding of altered cell behaviour as occurs during the migration, 
invasion, and metastasis of cancer cells. 
The p116Rip protein was first identified as a putative RhoA-interacting protein. It 
contains several protein interaction domains and is widely expressed throughout the body. 
Initial results suggested that p116Rip expression in neuronal cells inhibited RhoA-induced 
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contraction of the actin cytoskeleton. This thesis focuses on the function of p116Rip with 
emphasis on its role in RhoA-induced remodelling of the actin cytoskeleton and induction of 
gene transcription. 
 
Chapter 1 describes the major signal transduction pathways downstream of RhoA leading to 
gene transcription and remodelling of the actin cytoskeleton, especially in neuronal cells. 
Moreover, we characterise p116Rip: the conservation of p116Rip among diverse organisms, its 
chromosomal location, occurrence of splice variants, related proteins, domain structure, and 
potential protein-protein interaction and regulatory motifs. Furthermore, chapter 1 
summarizes published data on the presence of p116Rip in various protein complexes and its 
regulation under physiological conditions. 
In chapter 2 we show that p116Rip is an F-actin binding protein that co-localises to, 
binds and bundles filamentous actin through actin-binding domain(s) located at its N-
terminus. In addition, we show that overexpression of p116Rip in NIH3T3 cells leads to 
disruption of RhoA-dependent stress fibres and Rac-mediated lamellipodia formation, as 
shown by the formation of dendrite-like extensions. These findings indicate that p116Rip can 
affect, either directly or indirectly, the integrity of the actin cytoskeleton. 
In chapter 3 we show that p116Rip, through its C-terminal coiled-coil domain, 
interacts directly with the regulatory myosin-binding subunits (MBS) of myosin light chain 
(MLC) phosphatase, MBS85 and MBS130. MLC-phosphatase is a crucial component in the 
RhoA pathway. The function of p116Rip is investigated by blocking its expression using a 
recently developed technique, RNA interference (RNAi). This technique involves the 
production of small specific pieces of RNA that block expression of the corresponding 
protein. RNAi-induced knockdown of p116Rip inhibits cell spreading and neurite outgrowth in 
response to extracellular stimuli, demonstrating that p116Rip is essential for neurite 
outgrowth. RNAi-induced knockdown of p116Rip does not affect MLC phosphorylation; the 
association of MBS with the cytoskeleton appears to depend on p116Rip. We suggest a 
model in which p116Rip acts as a scaffold to target the myosin phosphatase complex to the 
actin cytoskeleton. 
Chapter 4 reports on the inhibition of RhoA-induced activation of the transcription 
factor SRF by p116Rip. However, overexpression of p116Rip does not directly affect RhoA 
activation. In addition, we demonstrate that p116Rip can oligomerise through its C-terminal 
coiled-coil domain. Mutational analysis revealed that transcriptional inhibition by p116Rip 
does not depend on the p116Rip-MBS interaction (chapter 3) or on oligomerisation. Exactly 
how this inhibition occurs is as yet unclear, but we propose that p116Rip abrogates RhoA-
induced SRF activation due to its ability to disassemble the F-actin cytoskeleton (chapter 2). 
We conclude that p116Rip counteracts RhoA signalling downstream of RhoA and Rho-kinase 
(ROCK). 
In conclusion, we have shown that p116Rip is essential for neurite outgrowth and 
counteracts RhoA action. This occurs downstream of RhoA and ROCK, probably at multiple 
levels: 1) by its direct effect on actin remodelling, 2) by acting as a scaffold linking MBS to 
the cytoskeleton. Further studies in primary neurons, should reveal how p116Rip regulates 
neurite outgrowth. Since p116Rip counteracts the RhoA pathway, it will be interesting to 






Cellen reageren op veranderingen in hun omgeving via sensoren, receptoren genaamd, die 
op de plasmamembraan liggen, aan de buitenkant van het celoppervlak. Prikkeling oftewel 
activering van receptoren door middel van binding van signaalstoffen aan een receptor, leidt 
tot specifieke reacties van een cel. Het signaal van de receptoren wordt vertaald en vanaf 
het celoppervlak doorgegeven naar het binnenste van de cel. Dit geschiedt via 
signaalwegen waarbij achtereenvolgende activatie van enzymen en generatie van nieuwe 
signalen optreedt (signaaltransductie). Welke veranderingen precies optreden in een cel na 
receptor stimulatie hangt af van de signaalstof, de receptor en de combinatie van beide. Zo 
zetten sommige signaalstoffen, zogenaamde groeifactoren, na binding aan de bijbehorende 
receptor, cellen aan tot delen. Op soortgelijke wijze kan activatie van receptoren naast 
verandering in celgroei leiden tot veranderingen in celmobiliteit en celmorfologie. 
Veranderingen in de celmorfologie en celpolariteit zijn fundamenteel voor vele fysiologische 
en tevens pathologische processen. Dynamische regulatie en organisatie van het cytoskelet 
liggen ten grondslag aan veranderingen in celmorfologie. 
Het cytoskelet zorgt voor de stevigheid en mobiliteit van een cel en bestaat uit drie 
verschillende typen netwerken: het actine cytoskelet, het microtubuli netwerk en de 
intermediaire filamenten. De vorm van deze netwerken wordt gekenmerkt door filamenten 
die ontstaan door aaneenschakeling van subeenheden in lange strengen (polymerisatie). 
Een hogere orde van actine cytoskeletstructuur wordt bereikt door het organiseren van 
actine filamenten in netwerken door crosslinking of bundelings eiwitten. Andere actine 
bindende eiwitten (ABP's) fungeren als “brug-eiwitten,” die het actine netwerk en 
associërende eiwitten ondersteunen en bijeenhouden. Daarnaast zijn er vele ABP's die de 
polymerisatie van actine subeenheden stimuleren of reduceren en daardoor de lengte en de 
hoeveelheid aan actine filamenten in de cel beϊnvloeden. De organisatie van het actine 
netwerk wordt dus bepaald door de gecombineerde activiteiten van ABP's. 
De Rho familie van kleine GTPases, in het bijzonder de leden RhoA, Rac en Cdc42, 
spelen een centrale rol in de regulatie van het actine cytoskelet. Rho GTPases zijn eiwitten 
die zich gedragen als moleculaire schakelaars: ze zijn inactief wanneer ze een complex 
vormen met GDP en actief als ze GTP-gebonden zijn. Receptoren die na activatie leiden tot 
veranderingen in de organisatie van het actine cytoskelet seinen alle via Rho GTPases. De 
Rho GTPases geven op hun beurt het signaal door naar eiwitten die de status van het actine 
cytoskelet direct of indirect beїnvloeden, zoals de ABP's. Zo resulteert RhoA activatie 
bijvoorbeeld in de contractie van cellen door stimulatie van het motoreiwit myosine, dat 
kracht uitoefent op actine filamenten. 
Daarnaast zijn Rho GTPases betrokken bij vele andere cellulaire reacties, zoals 
gentranscriptie, wat leidt tot specifieke veranderingen in eiwitproductie. Serum en het 
voornaamste bestanddeel van serum, lysophosphatidic acid, activeren de serum response 
factor (SRF) via een RhoA-afhankelijke toename van actine polymerisatie. SRF is een 
transcriptiefactor die veel groei-gerelateerde genen tot activiteit aanzet. 
Een verkeerde regulatie van Rho GTPase activiteit kan diverse aspecten van 
tumorontwikkeling bevorderen. Het bestuderen van de RhoA signaaltransductie route zal 
 95
Samenvatting 
ons begrip vergroten met betrekking tot veranderingen in celgedrag zoals die optreden 
tijdens de migratie, invasie en metastasering van kankercellen. 
p116Rip werd oorspronkelijk geїdentificeerd als een mogelijk RhoA-bindend eiwit 
(“RhoA-interacting protein”). Het eiwit wordt overal in het lichaam geproduceerd en bevat 
verschillende domeinen die potentiële interacties met andere eiwitten mogelijk maken. De 
eerste resultaten suggereerden dat p116Rip een remmende invloed had op de RhoA-
geϊnduceerde contractie van het actine cytoskelet . Dit proefschrift beschrijft de functie van 
p116Rip, waarbij de nadruk ligt op de rol die p116Rip speelt in de door RhoA veroorzaakte 
reorganisatie van het actine cytoskelet en activatie van gentranscriptie. 
 
Hoofdstuk 1 beschrijft de voornaamste signaaltransductie routes die via RhoA leiden tot 
gentranscriptie en reorganistie van het actine cytoskelet, met name in neuronale cellen. 
Tevens wordt p116Rip gekarakteriseerd: het voorkomen van het eiwit in diverse organismen, 
de chromosoomlokatie, splicevarianten, verwante eiwitten, de domeinstructuur en potentieel 
interessante eiwit-eiwit interacties. Daarnaast bevat hoofdstuk 1 een samenvatting van 
gegevens in de literatuur over de aanwezigheid van p116Rip in eiwitcomplexen en de 
regulatie van p116Rip tijdens fysiologische en pathologische processen. 
In hoofdstuk 2 tonen we aan dat p116Rip een actine-bindend eiwit is dat colokaliseert 
met actine filamenten en actine filamenten bundelt via actine bindend(e) domein(en) die 
gelokaliseerd zijn in de “kop” van het eiwit. Bovendien vinden we dat verhoogde p116Rip 
expressie leidt tot het verlies van (RhoA-afhankelijke) stress fibers en (Rac-geϊnduceerde) 
lamellipodia, hetgeen zich manifesteert als neuriet-achtige uitgroei. Dit suggereert dat 
p116Rip de integriteit van het actine cytoskelet kan beϊnvloeden. 
Hoofdstuk 3 beschrijft de binding van het coiled-coil domein van p116Rip aan de 
myosine-bindende subeenheden (MBS) van myosine light chain (MLC) phosphatase, 
MBS85 en MBS130. MLC phosphatase is een essentieel enzym in de RhoA 
signaaltransductie route. Verder wordt de functie van p116Rip bestudeerd door de expressie 
van het eiwit te blokkeren door middel van een recent ontwikkelde techniek, genaamd RNA-
interferentie (RNAi). Deze techniek maakt gebruik van de productie van kleine specifieke 
stukjes RNA, die expressie van het betreffende eiwit beletten. Remming van p116Rip 
eiwitproduktie leidt ertoe dat neuronale cellen zich niet meer goed kunnen uitspreiden en 
geen neurietuitgroei initiëren. Dit laat zien dat p116Rip essentieel is voor neurietuitgroei. 
Vervolgens werd bekeken of dit effect te maken had met de p116Rip partner MBS. Echter, 
verlaging van p116Rip eiwitproduktie heeft geen effect op MLC activiteit, maar wel op de 
associatie van MBS met het actine cytoskelet. Deze experimenten suggereren dat p116Rip 
als brug-eiwit fungeert om het MBS-complex te verbinden met het actine cytoskelet. 
In hoofdstuk 4 laten we zien dat overproduktie van p116Rip de (RhoA-geϊnduceerde) 
activatie van de transcriptiefactor SRF remt zonder een direct effect te hebben op de 
activiteit van RhoA zelf. Verder tonen we aan dat p116Rip met zichzelf kan oligomeriseren via 
het coiled-coil domein. Analyse door middel van mutanten laat zien dat deze remming 
onafhankelijk is van oligomerisatie of een interactie met MBS (zie hoofdstuk 3). Hoe deze 
remming precies in zijn werk gaat is onduidelijk. We concluderen dat p116Rip de RhoA 
signalering remt op een niveau dat zich beneden RhoA en Rho-kinase (ROCK) bevindt. 
Tot besluit wordt in dit proefschrift aangetoond dat p116Rip fundamenteel is voor 
neurietuitgroei en de werking van RhoA tenietdoet. Dit gebeurt waarschijnlijk op 
verschillende manieren: 1) door de reorganisatie van het actine cytoskelet direct te 
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beïnvloeden, 2) door te fungeren als een brug-eiwit om het MBS complex te verbinden aan 
het actine cytoskelet. Nader onderzoek in primaire neuronen zal moeten duidelijk maken hoe 
p116Rip precies betrokken is bij morfologische veranderingen van neuronale cellen. 
Aangezien p116Rip de normale RhoA signalering remt, is het bovendien interessant om de 
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